For: | Ferraioli G, Soares Monteiro LB. Ultrasound-based techniques for the diagnosis of liver steatosis. World J Gastroenterol 2019; 25(40): 6053-6062 [PMID: 31686762 DOI: 10.3748/wjg.v25.i40.6053] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v25/i40/6053.htm |
Number | Citing Articles |
1 |
Arsenii V Telichko, Rehman Ali, Thurston Brevett, Huaijun Wang, Jose G Vilches-Moure, Sukumar U Kumar, Ramasamy Paulmurugan, Jeremy J Dahl. Noninvasive estimation of local speed of sound by pulse-echo ultrasound in a rat model of nonalcoholic fatty liver. Physics in Medicine & Biology 2022; 67(1): 015007 doi: 10.1088/1361-6560/ac4562
|
2 |
Giovanna Ferraioli, Laura Maiocchi, Giovanni Savietto, Carmine Tinelli, Mara Nichetti, Mariangela Rondanelli, Fabrizio Calliada, Lorenzo Preda, Carlo Filice. Performance of the Attenuation Imaging Technology in the Detection of Liver Steatosis. Journal of Ultrasound in Medicine 2021; 40(7): 1325 doi: 10.1002/jum.15512
|
3 |
N. Seneviratne, C. Fang, P.S. Sidhu. Ultrasound-based hepatic fat quantification: current status and future directions. Clinical Radiology 2023; 78(3): 187 doi: 10.1016/j.crad.2022.10.003
|
4 |
SAKURA YAMAMURA, TAKUMI KAWAGUCHI, DAN NAKANO, YOSHIKO TOMIYASU, SHINOBU YOSHINAGA, YUMI DOI, HIROKAZU TAKAHASHI, KEIZO ANZAI, YUICHIRO EGUCHI, TAKUJI TORIMURA. Prevalence and Independent Factors for Fatty Liver and Significant Hepatic Fibrosis Using B-Mode Ultrasound Imaging and Two Dimensional-Shear Wave Elastography in Health Check-up Examinees. The Kurume Medical Journal 2019; 66(4): 225 doi: 10.2739/kurumemedj.MS664008
|
5 |
Alina Boeriu, Daniela Dobru, Crina Fofiu. Non-Invasive Diagnostic of NAFLD in Type 2 Diabetes Mellitus and Risk Stratification: Strengths and Limitations. Life 2023; 13(12): 2262 doi: 10.3390/life13122262
|
6 |
Bandana Kumari, Sadhana Sharma, Ramesh Kumar, Satish Dipankar, Bijaya N Naik, Ayan Banerjee, Sushil Kumar. Efficacy of Lipid Ratios and Platelet Distribution Width for Assessment of Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease. Cureus 2022; doi: 10.7759/cureus.21110
|
7 |
P. Gabriel-Medina, R. Ferrer-Costa, F. Rodriguez-Frias, M. Comas, R. Vilallonga, A. Ciudin, D. M. Selva. Plasma SHBG Levels as an Early Predictor of Response to Bariatric Surgery. Obesity Surgery 2024; 34(3): 760 doi: 10.1007/s11695-023-06981-w
|
8 |
Marco Dioguardi Burgio, Laurent Castera, Mehdi Oufighou, Pierre-Emmanuel Rautou, Valérie Paradis, Pierre Bedossa, Riccardo Sartoris, Maxime Ronot, Sylvain Bodard, Philippe Garteiser, Bernard Van Beers, Dominique Valla, Valérie Vilgrain, Jean Michel Correas. Prospective Comparison of Attenuation Imaging and Controlled Attenuation Parameter for Liver Steatosis Diagnosis in Patients With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes. Clinical Gastroenterology and Hepatology 2024; 22(5): 1005 doi: 10.1016/j.cgh.2023.11.034
|
9 |
Katarzyna Kozłowska-Petriczko, Ewa Wunsch, Jan Petriczko, Wing-Kin Syn, Piotr Milkiewicz. Diagnostic Accuracy of Non-Imaging and Ultrasound-Based Assessment of Hepatic Steatosis Using Controlled Attenuation Parameter (CAP) as Reference. Journal of Clinical Medicine 2021; 10(7): 1507 doi: 10.3390/jcm10071507
|
10 |
Xiaolu Weng, Jing Xu, Shouxing Yang. Association between the arm circumference and non-alcoholic fatty liver disease in American children and adolescence: a population-based analysis. Frontiers in Public Health 2024; 12 doi: 10.3389/fpubh.2024.1323795
|
11 |
Cihan Aydın, Nadir Emlek, Elif Ergül. Liver fibrosis scores and coronary artery ectasia. Kardiologiia 2023; 63(7): 62 doi: 10.18087/cardio.2023.7.n2258
|
12 |
Reinhard Kubale, Guenther Schneider, Carl P. N. Lessenich, Arno Buecker, Sebastian Wassenberg, Gabriela Torres, Arati Gurung, Timothy Hall, Yassin Labyed. Ultrasound-Derived Fat Fraction for Hepatic Steatosis Assessment: Prospective Study of Agreement With MRI PDFF and Sources of Variability in a Heterogeneous Population. American Journal of Roentgenology 2024; 222(6) doi: 10.2214/AJR.23.30775
|
13 |
Rossella Liani, Paola Giustina Simeone, Romina Tripaldi, Damiano D'Ardes, Valeria Creato, Raffaele Pepe, Gianfranco Lessiani, Giuseppina Bologna, Francesco Cipollone, Marco Marchisio, Paola Lanuti, Francesca Santilli. Kinetics of Circulating Extracellular Vesicles Over the 24‐Hour Dosing Interval After Low‐Dose Aspirin Administration in Patients at Cardiovascular Risk. Clinical Pharmacology & Therapeutics 2023; 113(5): 1096 doi: 10.1002/cpt.2865
|
14 |
Samuel J. Martínez-Domínguez, Sandra García-Mateo, Carla J. Gargallo-Puyuelo, Beatriz Gallego Llera, Engy Refaie, Pilar Callau, Carolina Mendi, Pedro M. Baptista, María Hernández Ainsa, María Teresa Arroyo-Villarino, Julia López de la Cruz, Javier Martínez-García, Erika Alfambra, Miguel Ángel Simón Marco, Javier Ampuero, Fernando Gomollón. Crohn´s disease is an independent risk factor for liver fibrosis in patients with inflammatory bowel disease and non-alcoholic fatty liver disease. European Journal of Internal Medicine 2024; 120: 99 doi: 10.1016/j.ejim.2023.10.019
|
15 |
Evgenia Koureta, Evangelos Cholongitas. Evolving role of semaglutide in NAFLD: in combination, weekly and oral administration. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1343587
|
16 |
Giovanna Ferraioli, Annalisa Berzigotti, Richard G. Barr, Byung I. Choi, Xin Wu Cui, Yi Dong, Odd Helge Gilja, Jae Young Lee, Dong Ho Lee, Fuminori Moriyasu, Fabio Piscaglia, Katsutoshi Sugimoto, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Christoph F. Dietrich. Quantification of Liver Fat Content with Ultrasound: A WFUMB Position Paper. Ultrasound in Medicine & Biology 2021; 47(10): 2803 doi: 10.1016/j.ultrasmedbio.2021.06.002
|
17 |
Gian Luca Erre, Floriana Castagna, Assunta Sauchella, Pierluigi Meloni, Arduino Aleksander Mangoni, Giuseppina Farina, Richard Woodman, Maria Pina Dore, Gianpaolo Vidili. Prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case–control study. Therapeutic Advances in Musculoskeletal Disease 2021; 13 doi: 10.1177/1759720X211042739
|
18 |
Audun M. Trelsgård, Anesa Mulabecirovic, Rafael Alexander Leiva, Ingrid K. Nordaas, Anders B. Mjelle, Odd Helge Gilja, Roald F. Havre. Multiparametric liver assessment in patients successfully treated for hepatitis C: a 4-year follow-up. Scandinavian Journal of Gastroenterology 2024; 59(10): 1184 doi: 10.1080/00365521.2024.2388691
|
19 |
Jinho Jung, Aiguo Han, Egbert Madamba, Ricki Bettencourt, Rohan R. Loomba, Andrew S. Boehringer, Michael P. Andre, John W. Erdman, William D. O’Brien, Kathryn J. Fowler, Claude B. Sirlin, Rohit Loomba. Direct Comparison of Quantitative US versus Controlled Attenuation Parameter for Liver Fat Assessment Using MRI Proton Density Fat Fraction as the Reference Standard in Patients Suspected of Having NAFLD. Radiology 2022; 304(1): 75 doi: 10.1148/radiol.211131
|
20 |
Claruza Braga Holanda Lavor, Antonio Brazil Viana Júnior, Francisco das Chagas Medeiros. Polycystic Ovary Syndrome and Metabolic Syndrome: Clinical and Laboratory Findings and Non-Alcoholic Fatty Liver Disease Assessed by Elastography. Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics 2022; 44(03): 287 doi: 10.1055/s-0041-1741032
|
21 |
Woori Chae, Kyung Jae Lee, Ki Young Huh, Jin Soo Moon, Jae Sung Ko, Joo-Youn Cho. Association of Metabolic Signatures with Nonalcoholic Fatty Liver Disease in Pediatric Population. Metabolites 2022; 12(9): 881 doi: 10.3390/metabo12090881
|
22 |
Jiajia Wang, Jinping Wang, Han Wang, Boqi Li, Yixing Wang, Lanting Sun, Xiaoqian Wu. Application of attenuation coefficient in the assessment of hepatic involvement in children and adolescents with Wilson’s disease. BMC Medical Imaging 2023; 23(1) doi: 10.1186/s12880-023-00979-7
|
23 |
S.Ye. Mostovyi, M.M. Zhaivoronok, O.M. Safonova. Ultrasound criteria for assessing the correction of metabolic-associated fatty liver disease and liver blood flow disorders using arginine in patients with coronary artery disease in combination with COVID-19. GASTROENTEROLOGY 2024; 58(2): 93 doi: 10.22141/2308-2097.58.2.2024.601
|
24 |
Jonathan Mertens, Luc F. Van Gaal, Sven M. Francque, Christophe De Block. NAFLD in type 1 diabetes: overrated or underappreciated?. Therapeutic Advances in Endocrinology and Metabolism 2021; 12 doi: 10.1177/20420188211055557
|
25 |
Kibo Nam, Mehnoosh Torkzaban, Dina Halegoua-DeMarzio, Corinne E Wessner, Andrej Lyshchik. Improving diagnostic accuracy of ultrasound texture features in detecting and quantifying hepatic steatosis using various beamforming sound speeds. Physics in Medicine & Biology 2023; 68(4): 04NT02 doi: 10.1088/1361-6560/acb635
|
26 |
Flavius F. Guglielmo, Richard G. Barr, Takeshi Yokoo, Giovanna Ferraioli, James T. Lee, Jonathan R. Dillman, Jeanne M. Horowitz, Kartik S. Jhaveri, Frank H. Miller, Roshan Y. Modi, Amirkasra Mojtahed, Michael A. Ohliger, Ali Pirasteh, Scott B. Reeder, Krishna Shanbhogue, Alvin C. Silva, Elainea N. Smith, Venkateswar R. Surabhi, Bachir Taouli, Christopher L. Welle, Benjamin M. Yeh, Sudhakar K. Venkatesh. Liver Fibrosis, Fat, and Iron Evaluation with MRI and Fibrosis and Fat Evaluation with US: A Practical Guide for Radiologists. RadioGraphics 2023; 43(6) doi: 10.1148/rg.220181
|
27 |
Atilla Bulur, Rıdvan Sivritepe. The Association between Non-Alcoholic Fatty Liver Disease and Dynapenia in Men Diagnosed with Type 2 Diabetes Mellitus. Healthcare 2023; 11(2): 243 doi: 10.3390/healthcare11020243
|
28 |
Bandik Föh, Friedhelm Sayk, Jens U Marquardt. Neue Entwicklungen in der Diagnostik und Therapie der metabolisch assoziierten, nicht-alkoholischen Fettlebererkrankung. Adipositas - Ursachen, Folgeerkrankungen, Therapie 2021; 15(03): 121 doi: 10.1055/a-1491-5792
|
29 |
Marie Byenfeldt, Johan Kihlberg, Patrik Nasr, Christer Grönlund, Anna Lindam, Wolf C. Bartholomä, Peter Lundberg, Mattias Ekstedt. Altered probe pressure and body position increase diagnostic accuracy for men and women in detecting hepatic steatosis using quantitative ultrasound. European Radiology 2024; 34(9): 5989 doi: 10.1007/s00330-024-10655-1
|
30 |
Marta Magaz, Heloïse Giudicelli-Lett, Juan G. Abraldes, Oana Nicoară-Farcău, Fanny Turon, Neil Rajoriya, Ashish Goel, Karlien Raymenants, Sophie Hillaire, Luis Téllez, Laure Elkrief, Bogdan Procopet, Lara Orts, Filipe Nery, Akash Shukla, Hélène Larrue, Helena Degroote, Victoria Aguilera, Elba Llop, Laura Turco, Federica Indulti, Stefania Gioia, Giulia Tosetti, Niccolò Bitto, Chiara Becchetti, Edilmar Alvarado, Cristina Roig, Raquel Diaz, Michael Praktiknjo, Anna-Lena Konicek, Pol Olivas, José Ignacio Fortea, Helena Masnou, Ángela Puente, Alba Ardèvol, Carmen A. Navascués, Marta Romero-Gutiérrez, Bernhard Scheiner, Georg Semmler, Mattias Mandorfer, Filipe Damião, Anna Baiges, Asunción Ojeda, Macarena Simón-Talero, Carlos González-Alayón, Alba Díaz, Ángeles García-Criado, Andrea De Gottardi, Manuel Hernández-Guerra, Joan Genescà, Nicolas Drilhon, Carlos Noronha Ferreira, Thomas Reiberger, Manuel Rodríguez, Rosa María Morillas, Javier Crespo, Jonel Trebicka, Rafael Bañares, Càndid Villanueva, Annalisa Berzigotti, Massimo Primignani, Vincenzo La Mura, Oliviero Riggio, Filippo Schepis, Xavier Verhelst, José Luis Calleja, Christophe Bureau, Agustín Albillos, Frederik Nevens, Virginia Hernández-Gea, Dhiraj Tripathi, Pierre-Emmanuel Rautou, Juan Carlos García-Pagán. Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome. Journal of Hepatology 2024; doi: 10.1016/j.jhep.2024.07.035
|
31 |
Xinyue Wang, Wei Zhang, Jiale Huang, Hongwei Li, Jian Gao. The relationship between vitamin K and metabolic dysfunction-associated fatty liver disease among the United States population: National Health and Nutrition Examination Survey 2017–2018. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1086477
|
32 |
Zhili Jiang, Xiang Li, Duo Yang, Chao Qu, Jiayi Yi, Hai Gao. Development and validation of a risk score for detecting non-alcoholic fatty liver disease. Medicine 2024; 103(46): e40417 doi: 10.1097/MD.0000000000040417
|
33 |
Max Zalcman, Richard A. Barth, Erika Rubesova. Real-time ultrasound-derived fat fraction in pediatric population: feasibility validation with MR-PDFF. Pediatric Radiology 2023; 53(12): 2466 doi: 10.1007/s00247-023-05752-0
|
34 |
Ruixiang Qi, Liren Lu, Ting He, Liqing Zhang, Yiting Lin, Lingyun Bao. Comparing ultrasound-derived fat fraction and MRI-PDFF for quantifying hepatic steatosis: a real-world prospective study. European Radiology 2024; doi: 10.1007/s00330-024-11119-2
|
35 |
Guotai Sheng, Nan Peng, Chong Hu, Ling Zhong, Mingchun Zhong, Yang Zou. The albumin-to-alkaline phosphatase ratio as an independent predictor of future non-alcoholic fatty liver disease in a 5-year longitudinal cohort study of a non-obese Chinese population. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01479-9
|
36 |
Eirini Martinou, Marinos Pericleous, Irena Stefanova, Vasha Kaur, Angeliki M. Angelidi. Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches. Diagnostics 2022; 12(2): 407 doi: 10.3390/diagnostics12020407
|
37 |
Adrien Rohfritsch, Emilie Franceschini, Aurélien Dupré, David Melodelima. Quantitative ultrasound techniques for assessing thermal ablation: Measurement of the backscatter coefficient from ex vivo human liver. Medical Physics 2023; 50(11): 6908 doi: 10.1002/mp.16762
|
38 |
Sarah El-Nakeep, Enas Foda, Aliaa S. Sheha, Sara Mohamed Abdelazeem, Ghada Abdelrahman Mohamed. Magnetic resonance spectroscopy as a diagnostic model for assessment of liver steatosis in metabolic dysfunction-associated steatotic liver disease in non-diabetic patients. Egyptian Journal of Radiology and Nuclear Medicine 2024; 55(1) doi: 10.1186/s43055-024-01342-8
|
39 |
Rachel Gingold-Belfer, Nadav Shinhar, Gil N. Bachar, Nidal Issa, Doron Boltin, Eran Sharon, Tzippy Shohat, Boris Sapoznikov, Ariel Swartz, Noam Peleg, Tom Konikoff, Hemda Schmilovitz-Weiss. Predictors of poor outcome following liver biopsy for the investigation of new hepatic space occupying lesion/s. Clinical Imaging 2023; 99: 19 doi: 10.1016/j.clinimag.2023.04.001
|
40 |
Giovanna Ferraioli, Richard G. Barr. Multiparametric Ultrasound for the Assessment of Diffuse Liver Disease. 2024; : 177 doi: 10.1016/B978-0-323-87479-3.00020-X
|
41 |
Matteo Rosselli, Davide Roccarina, Ivica Grgurevic. Liver Ultrasound. 2023; : 124 doi: 10.1002/9781119612650.ch8
|
42 |
Allwyn S. Rajamani, Ashwin Rammohan, V.V.Raghavendra Sai, Mohamed Rela. Current techniques and future trends in the diagnosis of hepatic steatosis in liver donors: A review. Journal of Liver Transplantation 2022; 7: 100091 doi: 10.1016/j.liver.2022.100091
|
43 |
Emrah Doğan, Ferda Bacaksızlar Sarı. Is Fat Deposition of Renal Sinus a Concomitant Finding to Fatty Liver Disease? The First Study Regarding the Relationship Between Kidney and Liver Fat Content with Non-Contrast Computed Tomography. Spartan Medical Research Journal 2022; 7(1) doi: 10.51894/001c.32411
|
44 |
Bowen Li, Dar-In Tai, Ke Yan, Yi-Cheng Chen, Cheng-Jen Chen, Shiu-Feng Huang, Tse-Hwa Hsu, Wan-Ting Yu, Jing Xiao, Lu Le, Adam P Harrison. Accurate and generalizable quantitative scoring of liver steatosis from ultrasound images <i>via</i> scalable deep learning. World Journal of Gastroenterology 2022; 28(22): 2494-2508 doi: 10.3748/wjg.v28.i22.2494
|
45 |
O. S. Popova, V. S. Ponamarev, A. V. Kostrova, L. A. Agafonova. Use of modern methods for diagnostics of diseases of the heptobiliary system. International Journal of Veterinary Medicine 2023; (1): 113 doi: 10.52419/issn2072-2419.2023.1.113
|
46 |
Abeer Attia, Nargis Albert Labib, Noha Essameldin Elsayed Abdelzaher, Sherief Musa, Mira Atef. Lifestyle determinants as predictor of severity of metabolic associated fatty liver disease (MAFLD). Egyptian Liver Journal 2023; 13(1) doi: 10.1186/s43066-023-00282-8
|
47 |
Farkhondeh Razmpour, Reza Daryabeygi-Khotbehsara, Davood Soleimani, Hamzeh Asgharnezhad, Afshar Shamsi, Ghasem Sadeghi Bajestani, Mohsen Nematy, Mahdiyeh Razm Pour, Ralph Maddison, Sheikh Mohammed Shariful Islam. Application of machine learning in predicting non-alcoholic fatty liver disease using anthropometric and body composition indices. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-32129-y
|
48 |
Zahaan Vakil, Kiran Ahire. Clinical Profile of Nonalcoholic Fatty Liver Disease and its Correlation with Metabolic Syndrome and Cardiovascular Risk. International Journal of Applied & Basic Medical Research 2023; 13(4): 234 doi: 10.4103/ijabmr.ijabmr_138_23
|
49 |
Sun Kyung Jeon, Jeong Min Lee. Inter-platform reproducibility of ultrasound-based fat fraction for evaluating hepatic steatosis in nonalcoholic fatty liver disease. Insights into Imaging 2024; 15(1) doi: 10.1186/s13244-024-01611-0
|
50 |
Matthew Thomas, Manjiri Dighe, Orpheus Kolokythas, Mladen Zecevic, Ann Wilson, Todd Erpelding, Theodore J. Dubinsky. Ultrasound Attenuation Imaging vs MRI-PDFF, Echogenicity and Liver Function for Assessing Degree of Steatosis in NAFLD and Non-NAFLD Patients. Ultrasound Quarterly 2023; doi: 10.1097/RUQ.0000000000000648
|
51 |
Grit Zahn, Diana M. Willmes, Nermeen N. El-Agroudy, Christopher Yarnold, Richard Jarjes-Pike, Sabine Schaertl, Kay Schreiter, Wiebke Gehrmann, Andrea Kuan Cie Wong, Tommaso Zordan, Jörg König, Jens Jordan, Andreas L. Birkenfeld. A Novel and Cross-Species Active Mammalian INDY (NaCT) Inhibitor Ameliorates Hepatic Steatosis in Mice with Diet-Induced Obesity. Metabolites 2022; 12(8): 732 doi: 10.3390/metabo12080732
|
52 |
Nobuharu Tamaki, Veeral Ajmera, Rohit Loomba. Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD. Nature Reviews Endocrinology 2022; 18(1): 55 doi: 10.1038/s41574-021-00584-0
|
53 |
Christophe Cassinotto, Tony Jacq, Sophie Anselme, José Ursic-Bedoya, Pierre Blanc, Stéphanie Faure, Ali Belgour, Boris Guiu. Diagnostic Performance of Attenuation to Stage Liver Steatosis with MRI Proton Density Fat Fraction as Reference: A Prospective Comparison of Three US Machines. Radiology 2022; 305(2): 353 doi: 10.1148/radiol.212846
|
54 |
Saleh A Alqahtani, Jörn M Schattenberg. Nonalcoholic fatty liver disease: use of diagnostic biomarkers and modalities in clinical practice. Expert Review of Molecular Diagnostics 2021; 21(10): 1065 doi: 10.1080/14737159.2021.1964958
|
55 |
Eris Ozkan, Mahmut Gok, Hakki Cetinkaya, Mustafa Kaplan, Gulizar Sahin. Comparison of focal segmental glomerulosclerosis and other primary glomerulonephrites in terms of parameters of hepatic steatosis and metabolic syndrome. International Urology and Nephrology 2023; 55(10): 2557 doi: 10.1007/s11255-023-03536-x
|
56 |
Mohamed Ahmed Samy Kohla, Ahmed El Fayoumi, Eman Abdelsameea, Maha Elsabaawy, Rasha Abdelhafiz Aly, Sally Waheed Elkhadry, Medhat Assem. Comparison of transient elastography and shear wave elastography in patients with MAFLD: A single-center experience. Romanian Journal of Internal Medicine 2024; 62(3): 331 doi: 10.2478/rjim-2024-0019
|
57 |
Halit Nahit Şendur, Mahi Nur Cerit, Nemat Ibrahimkhanli, Aylin Billur Şendur, Suna Özhan Oktar. Interobserver Variability in Ultrasound‐Based Liver Fat Quantification. Journal of Ultrasound in Medicine 2023; 42(4): 833 doi: 10.1002/jum.16048
|
58 |
Stefan Kabisch, Mariya Markova, Silke Hornemann, Stephanie Sucher, Olga Pivovarova-Ramich, Jürgen Machann, Johannes Hierholzer, Sascha Rohn, Andreas F. H. Pfeiffer. Liver fat scores do not reflect interventional changes in liver fat content induced by high-protein diets. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-87360-2
|
59 |
Alice Elena Ghenea, Vlad Pădureanu, Ramona Cioboată, Anca-Loredana Udriștoiu, Andrei Ioan Drocaş, Eugen Țieranu, Mara Carsote, Corina Maria Vasile, Aritina Moroşanu, Viorel Biciușcă, Alex-Ioan Salan, Adriana Turculeanu, Anca Ungureanu. The Study of Clinical and Biochemical Parameters in Assessing the Response to the Antiviral Therapy in the Chronic Viral Hepatitis B. Medicina 2021; 57(8): 757 doi: 10.3390/medicina57080757
|
60 |
Sara Volpe, Giuseppe Lisco, Margherita Fanelli, Davide Racaniello, Valentina Colaianni, Domenico Triggiani, Rossella Donghia, Lucilla Crudele, Roberta Rinaldi, Carlo Sabbà, Vincenzo Triggiani, Giovanni De Pergola, Giuseppina Piazzolla. Once-Weekly Subcutaneous Semaglutide Improves Fatty Liver Disease in Patients with Type 2 Diabetes: A 52-Week Prospective Real-Life Study. Nutrients 2022; 14(21): 4673 doi: 10.3390/nu14214673
|
61 |
Akira YAMADA, Eriko YOSHIZAWA. Quantitative assessment of liver steatosis using ultrasound: dual-energy CT. Choonpa Igaku 2023; 50(3): 189 doi: 10.3179/jjmu.JJMU.R.222
|
62 |
Kavya Koneru, Varsha Bhatt, Arjun Kakrani, Manaswini Edara, Vuluvala T. Reddy, Pranav Gopal Jawade. A study of non-alcoholic fatty liver disease-liver fat score in overweight and obese individuals. Journal of Family Medicine and Primary Care 2022; 11(8): 4368 doi: 10.4103/jfmpc.jfmpc_58_22
|
63 |
Shuang Luo, Xiaolu Weng, Jing Xu, Hao Lin. Correlation between ZJU index and hepatic steatosis and liver fibrosis in American adults with NAFLD. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1443811
|
64 |
Richard G. Barr. Multiparametric Ultrasound for the Assessment of Diffuse Liver Disease. 2024; : 7 doi: 10.1016/B978-0-323-87479-3.00011-9
|
65 |
Anubha Srivastava, Rajat Pandey, Smriti Singh. A HOSPITAL BASED STUDY IN TERTIARY CARE CENTRE IN NORTH INDIA: PREVALENCE OF NAFLD IN PATIENTS OF PREDIABETES AND DIABETES. GLOBAL JOURNAL FOR RESEARCH ANALYSIS 2022; : 50 doi: 10.36106/gjra/8706621
|
66 |
Giovanna Ferraioli, Ambra Raimondi, Laura Maiocchi, Annalisa De Silvestri, Gianluigi Poma, Viksit Kumar, Richard G Barr. Liver Fat Quantification With Ultrasound: Depth Dependence of Attenuation Coefficient. Journal of Ultrasound in Medicine 2023; 42(10): 2247 doi: 10.1002/jum.16242
|
67 |
Mariana F. Leite, Ariele B. Haagsma, Paulo-André B. Machado-Júnior, Grasiele L. Martins, Márcia Olandoski, Cristina P. Baena. Association between serum uric acid levels and incidence of nonalcoholic fatty liver disease in users of preventive medicine service in southern Brazil: a retrospective study. Bulletin of the National Research Centre 2022; 46(1) doi: 10.1186/s42269-022-00848-3
|
68 |
Divna Popović, Stefan Rošić, Snežana Lukić. Incidence of different types of irritable bowel syndrome in patients with nonalcoholic fatty liver. Medicinski podmladak 2022; 73(2): 6 doi: 10.5937/mp73-33427
|
69 |
David T. Fetzer, Ivan M. Rosado-Mendez, Michael Wang, Michelle L. Robbin, Arinc Ozturk, Keith A. Wear, Juvenal Ormachea, Timothy A. Stiles, J. Brian Fowlkes, Timothy J. Hall, Anthony E. Samir. Pulse-Echo Quantitative US Biomarkers for Liver Steatosis: Toward Technical Standardization. Radiology 2022; 305(2): 265 doi: 10.1148/radiol.212808
|
70 |
Jiaofeng Huang, Rahul Kumar, Mingfang Wang, Yueyong Zhu, Su Lin. MAFLD criteria overlooks a number of patients with severe steatosis: Is it clinically relevant?. Journal of Hepatology 2020; 73(5): 1265 doi: 10.1016/j.jhep.2020.06.016
|
71 |
Giovana N. W. Ito, Vinícius A. C. Rodrigues, Juliana Hümmelgen, Gustavo S. P. G. Meschino, Gustavo M. Abou‐Rejaile, Isadora D. Brenny, Carlos R. de Castro Júnior, Rafaela C. Artigas, João Pedro S. Munhoz, Gabriela C. Cardoso, Guilherme F. Picheth. COVID‐19 pathophysiology and ultrasound imaging: A multiorgan review. Journal of Clinical Ultrasound 2022; 50(3): 326 doi: 10.1002/jcu.23160
|
72 |
Yang Xiao, Han Wang, Lina Han, Guorong Lyu, Shilin Li. Effect of uric acid on lipid metabolism assessed via restricted cubic splines: A new insight. Heliyon 2024; 10(17): e37408 doi: 10.1016/j.heliyon.2024.e37408
|
73 |
A. S. Kuznetsova, A. I. Dolgushina, A. A. Selyanina, T. A. Sokolova, E. R. Olevskaya, V. V. Genkel. The FINDRISC scale as a risk assessment tool for liver fibrosis in patients with nonalcoholic fatty liver disease. Obesity and metabolism 2022; 19(3): 252 doi: 10.14341/omet12832
|
74 |
Nobuharu Tamaki, Masayuki Kurosaki, Yutaka Yasui, Kaoru Tsuchiya, Namiki Izumi. Attenuation coefficient (ATT) measurement for liver fat quantification in chronic liver disease. Journal of Medical Ultrasonics 2021; 48(4): 481 doi: 10.1007/s10396-021-01103-4
|
75 |
Yuh-Ying Liu, Chih-Lang Lin, Cheng-Hao Weng, Pei-Hung Chang, Cheng-Hung Chien, Kuang-Chen Huang, Man-Chin Hua, Ching-Chih Hu. Older Age and High α-Fetoprotein Predict Higher Risk of Hepatocellular Carcinoma in Chronic Hepatitis-B-Related Cirrhotic Patients Receiving Long-Term Nucleos(t)ide Analogue Therapy. Diagnostics 2022; 12(9): 2085 doi: 10.3390/diagnostics12092085
|
76 |
Elaine J. Abrams, Jennifer Jao, Hlengiwe P. Madlala, Allison Zerbe, Patrick Catalano, Mariana Gerschenson, Julia H. Goedecke, Yolanda Gomba, Jami Josefson, Irwin J. Kurland, Justine Legbedze, Grace A. McComsey, Sandisiwe Matyesini, Elton Mukonda, Daniel Robinson, Landon Myer, Marianne Clemence. An observational cohort study to investigate the impact of dolutegravir in pregnancy and its obesogenic effects on the metabolic health of women living with HIV and their children: Study protocol. PLOS ONE 2024; 19(8): e0307296 doi: 10.1371/journal.pone.0307296
|
77 |
Tommaso Vincenzo Bartolotta, Adele Taibbi, Angelo Randazzo, Cesare Gagliardo. New frontiers in liver ultrasound: From mono to multi parametricity. World Journal of Gastrointestinal Oncology 2021; 13(10): 1302-1316 doi: 10.4251/wjgo.v13.i10.1302
|
78 |
Ahmed Ragab, Ali M Abdel Fattah, Ahmed Reda Sayed, Sameh Fayek GamalEl Din, Shrouk Matrawy Mahmoud Hassan, Aya Yaseen Mohamed Mohamed, Mostafa Ahmed Hamed. Correlation between Serum Levels of Nitric Oxide and Adropin and Erectile Dysfunction in Males with Nonalcoholic Fatty Liver Disease: An Observational Study. Reproductive Sciences 2024; 31(9): 2676 doi: 10.1007/s43032-024-01537-4
|
79 |
Federica Vernuccio, Roberto Cannella, Tommaso Vincenzo Bartolotta, Massimo Galia, An Tang, Giuseppe Brancatelli. Advances in liver US, CT, and MRI: moving toward the future. European Radiology Experimental 2021; 5(1) doi: 10.1186/s41747-021-00250-0
|
80 |
Yanan Zhao, Minyue Jia, Chao Zhang, Xinxu Feng, Jifan Chen, Qunying Li, Yingying Zhang, Wen Xu, Yiping Dong, Yifan Jiang, Yajing Liu, Pintong Huang. Reproducibility of ultrasound-guided attenuation parameter (UGAP) to the noninvasive evaluation of hepatic steatosis. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-06879-0
|
81 |
Rosanna Villani, Grazia Pia Magnati, Giulia Tuccari, Moris Sangineto, Antonino Davide Romano, Tommaso Cassano, Gaetano Serviddio. Liver fat content assessed by conventional B-mode ultrasound and metabolic profile in non-diabetic patients: Implications for clinical practice. Ultrasound 2023; 31(3): 177 doi: 10.1177/1742271X221122585
|
82 |
Paola Mogna-Peláez, José I. Riezu-Boj, Fermin I. Milagro, José I. Herrero, Mariana Elorz, Alberto Benito-Boillos, Ana Luz Tobaruela-Resola, Josep A. Tur, J Alfredo Martínez, Itziar Abete, M. Angeles Zulet. Inflammatory markers as diagnostic and precision nutrition tools for metabolic dysfunction-associated steatotic liver disease: Results from the Fatty Liver in Obesity trial. Clinical Nutrition 2024; 43(7): 1770 doi: 10.1016/j.clnu.2024.05.042
|
83 |
Pablo Gabriel-Medina, Roser Ferrer-Costa, Andreea Ciudin, Salvador Augustin, Jesus Rivera-Esteban, J. M. Pericàs, D. M. Selva, Francisco Rodriguez-Frias. Accuracy of a sequential algorithm based on FIB-4 and ELF to identify high-risk advanced liver fibrosis at the primary care level. Internal and Emergency Medicine 2024; 19(3): 745 doi: 10.1007/s11739-023-03441-2
|
84 |
Antonietta Gerarda Gravina, Raffaele Pellegrino, Mario Romeo, Lorenzo Ventriglia, Flavia Scognamiglio, Concetta Tuccillo, Carmelina Loguercio, Alessandro Federico. The use of bicarbonate-sulphate-calcium-magnesium and sodium-low drinkable water improves functional gastrointestinal symptoms in patients with non-alcoholic fatty liver disease: A prospective study. Clinical Nutrition ESPEN 2023; 57: 281 doi: 10.1016/j.clnesp.2023.07.008
|
85 |
J.A. Velarde-Ruiz Velasco, D.K. Tapia Calderón, E. Llop Herrera, G. Castro Narro, E.S. García Jiménez, E. Cerda Reyes, F. Higuera de la Tijera, A.D. Cano Contreras, R. Moreno Alcántar, R.M. Chávez Ramírez, J.L. Calleja Panero. Más allá de la exploración física convencional en hepatología: POCUS. Revista de Gastroenterología de México 2023; 88(4): 381 doi: 10.1016/j.rgmx.2023.07.003
|
86 |
Yan Zhou, Mengjin Nie, Hongyu Zhou, Feng Mao, Lin Zhao, Jianmin Ding, Xiang Jing. Head-to-head comparison of three different US-based quantitative parameters for hepatic steatosis assessment: a prospective study. Abdominal Radiology 2024; 49(7): 2262 doi: 10.1007/s00261-024-04347-z
|
87 |
Giovanna Ferraioli, Ambra Raimondi, Annalisa De Silvestri, Carlo Filice, Richard G. Barr. Toward acquisition protocol standardization for estimating liver fat content using ultrasound attenuation coefficient imaging. Ultrasonography 2023; 42(3): 446 doi: 10.14366/usg.23014
|
88 |
B.N. Ezenwuba, C.M. Hynes. Ultrasound screening of paediatric non-alcoholic fatty liver disease (NAFLD): A critical literature review. Radiography 2024; 30(5): 1317 doi: 10.1016/j.radi.2024.07.006
|
89 |
Sushant M. Ranadive, Adriana Lofrano-Porto, Edgard M. K. V. K. Soares, Lauren Eagan, Luiz Guilherme Grossi Porto, Denise L. Smith. Low testosterone and cardiometabolic risks in a real-world study of US male firefighters. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-93603-z
|
90 |
Giulia Besutti, Lisa Bonilauri, Elisa Manicardi, Francesco Venturelli, Efrem Bonelli, Filippo Monelli, Valeria Manicardi, Luca Valenti, Guido Ligabue, Susanna Schianchi, Marco Massari, Nicoletta Riva, Elisabetta Froio, Elena Tagliavini, Pierpaolo Pattacini, Paolo Giorgi Rossi. Feasibility and efficiency of European guidelines for NAFLD assessment in patients with type 2 diabetes: A prospective study. Diabetes Research and Clinical Practice 2021; 177: 108882 doi: 10.1016/j.diabres.2021.108882
|
91 |
Semvua B. Kilonzo, Eliud Kamala, Hyasinta Jaka, Patrick Ngoya. Non-alcoholic fatty liver disease in Tanzania: prevalence, determinants, and diagnostic performance of triglycerides-glucose index and triglycerides-glucose index –body mass index compared to the hepatic ultrasound in overweight and obese individuals. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03164-4
|
92 |
Can Tuzer, Yasar Sertbas, Emrah Duman, Sabiha Komoglu, Omer Kan, Seval Ay, Abdurrahman Yigit, Meltem Sertbas, Nalan Okuroglu, Birgul Ozen, Aysegul Dalbeler, Ali Ozdemir. The role of mean platelet volume in nonalcoholic fatty liver disease without cardiovascular comorbidities, obesity and diabetes mellitus. European Journal of Gastroenterology & Hepatology 2021; 33(9): 1222 doi: 10.1097/MEG.0000000000002189
|
93 |
Arinc Ozturk, Viksit Kumar, Theodore T. Pierce, Qian Li, Masoud Baikpour, Ivan Rosado-Mendez, Michael Wang, Peng Guo, Scott Schoen, Yuyang Gu, Sunethra Dayavansha, Joseph R. Grajo, Anthony E. Samir. The Future Is Beyond Bright: The Evolving Role of Quantitative US for Fatty Liver Disease. Radiology 2023; 309(2) doi: 10.1148/radiol.223146
|
94 |
Annalisa Cespiati, Salvatore Petta, Rosa Lombardi, Vito Di Marco, Vincenza Calvaruso, Cristina Bertelli, Giuseppina Pisano, Erika Fatta, Giordano Sigon, Federica Iuculano, Luciano Crapanzano, Gerlando Gibilaro, Paolo Francione, Antonio Craxì, Silvia Fargion, Anna Ludovica Fracanzani. Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP). Digestive and Liver Disease 2021; 53(10): 1301 doi: 10.1016/j.dld.2020.11.001
|
95 |
Giovanna Ferraioli, Viksit Kumar, Arinc Ozturk, Kibo Nam, Chris L. de Korte, Richard G. Barr. US Attenuation for Liver Fat Quantification: An AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative. Radiology 2022; 302(3): 495 doi: 10.1148/radiol.210736
|
96 |
Samira Faraji, Mohammad Reza Mohammad Hosseini Azar, Mohammad Alizadeh. Brewed chicory leaf consumption has unexpected side effects along beneficial effects on liver enzymes in non-alcoholic fatty liver disease patients. Journal of Herbal Medicine 2022; 34: 100572 doi: 10.1016/j.hermed.2022.100572
|
97 |
Lu Liu, Xiaolan Shi, Jingwen Gao, Chunfang Xu, Xiaolin Liu. Predictive Risk Factors of Nonalcoholic Fatty Liver Disease in a Lean Chinese Population. Journal of Personalized Medicine 2022; 12(12): 1958 doi: 10.3390/jpm12121958
|
98 |
Vincenzo Cianci, Cristina Mondello, Gennaro Baldino, Giovanna Spatari, Angela Alibrandi, Alessio Cianci, Annalisa Cracò, Patrizia Gualniera, Alessio Asmundo, Michele Gaeta, Concetto Giorgianni, Daniela Sapienza. Potential contribution of GST-T1 and GST-M1 polymorphisms in the onset of hepatic steatosis: from radiological to molecular and medico-legal analyses. Frontiers in Gastroenterology 2024; 3 doi: 10.3389/fgstr.2024.1393282
|
99 |
Monica Lupsor-Platon, Teodora Serban, Alexandra-Iulia Silion, Alexandru Tirpe, Mira Florea. Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Step Forward for Better Evaluation Using Ultrasound Elastography. Cancers 2020; 12(10): 2778 doi: 10.3390/cancers12102778
|
100 |
Kiseok Kim, Yong-Jin Lee, Soon-Chan Kwon, Young-Sun Min, Hyun Kyo Lee, Gwangin Baek, Sang Hyeon Kim, Eun-Chul Jang. Correlation between shift work and non-alcoholic fatty liver disease among male workers in the steel manufacturing company of Korea: a cross-sectional study. Annals of Occupational and Environmental Medicine 2022; 34(1) doi: 10.35371/aoem.2022.34.e33
|
101 |
Yu‐Ming Cheng, Tsung‐Han Hsieh, Chia‐Chi Wang, Jia‐Horng Kao. Overlapping group between non‐alcoholic fatty liver disease and metabolic associated fatty liver disease better for liver research. JGH Open 2024; 8(10) doi: 10.1002/jgh3.70039
|
102 |
Yang Yang, Jing Liu, Changxuan Sun, Yuwei Shi, Julianna C. Hsing, Aya Kamya, Cody Auston Keller, Neha Antil, Daniel Rubin, Hongxia Wang, Haochao Ying, Xueyin Zhao, Yi-Hsuan Wu, Mindie Nguyen, Ying Lu, Fei Yang, Pinton Huang, Ann W. Hsing, Jian Wu, Shankuan Zhu. Nonalcoholic fatty liver disease (NAFLD) detection and deep learning in a Chinese community-based population. European Radiology 2023; 33(8): 5894 doi: 10.1007/s00330-023-09515-1
|
103 |
Zhi Xin Tan, Bryan Mehta, Kieran Kusel, James Seow, Marilyn Zelesco, Steven Abbott, Rebecca Simons, Glenn Boardman, Christopher J. Welman, Oyekoya T. Ayonrinde. Hepatic steatosis: Qualitative and quantitative sonographic assessment in comparison to histology. Australasian Journal of Ultrasound in Medicine 2024; 27(3): 179 doi: 10.1002/ajum.12381
|
104 |
Cara E. Morin, Amy B. Kolbe, Adina Alazraki, Govind B. Chavhan, Annie Gill, Juan Infante, Geetika Khanna, HaiThuy N. Nguyen, Allison F. O'Neill, Mitchell A. Rees, Akshay Sharma, James E. Squires, Judy H. Squires, Ali B. Syed, Elizabeth R. Tang, Alexander J. Towbin, Gary R. Schooler. Cancer Therapy–related Hepatic Injury in Children: Imaging Review from the Pediatric LI-RADS Working Group. RadioGraphics 2023; 43(9) doi: 10.1148/rg.230007
|
105 |
Christoph F. Dietrich, Long Shi, Axel Löwe, Yi Dong, Andrej Potthoff, Zeno Sparchez, Andreas Teufel, Sabine Guth, Jonas Koch, Richard G Barr, Xin-Wu Cui. Conventional ultrasound for diagnosis of hepatic steatosis is better than believed. Zeitschrift für Gastroenterologie 2022; 60(08): 1235 doi: 10.1055/a-1491-1771
|
106 |
Haoxuan Zou, Xiaopu Ma, Wen Pan, Yan Xie. Comparing similarities and differences between NAFLD, MAFLD, and MASLD in the general U.S. population. Frontiers in Nutrition 2024; 11 doi: 10.3389/fnut.2024.1411802
|
107 |
Farah Khaznadar, Ana Petrovic, Omar Khaznadar, Hrvoje Roguljic, Kristina Bojanic, Lucija Kuna Roguljic, Stjepan Siber, Robert Smolic, Ines Bilic-Curcic, George Y. Wu, Martina Smolic. Biomarkers for Assessing Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus on Sodium–Glucose Cotransporter 2 Inhibitor Therapy. Journal of Clinical Medicine 2023; 12(20): 6561 doi: 10.3390/jcm12206561
|
108 |
Jing Gao, Rebecca Lee, Michael Trujillo. Reliability of Performing Multiparametric Ultrasound in Adult Livers. Journal of Ultrasound in Medicine 2022; 41(3): 699 doi: 10.1002/jum.15751
|
109 |
Laura De Rosa, Antonio Salvati, Ferruccio Bonino, Maurizia Rossana Brunetto, Libertario Demi, Francesco Faita. Non-invasive Quantification of Steatosis: A New Ultrasound based Model to Predict Fatty Liver Content. 2022 IEEE International Ultrasonics Symposium (IUS) 2022; : 1 doi: 10.1109/IUS54386.2022.9958648
|
110 |
Guillermo Quintás, Florian Caiment, Iván Rienda, Judith Pérez-Rojas, Eugenia Pareja, José V. Castell, Ramiro Jover. Quantitative Prediction of Steatosis in Patients with Non-Alcoholic Fatty Liver by Means of Hepatic MicroRNAs Present in Serum and Correlating with Hepatic Fat. International Journal of Molecular Sciences 2022; 23(16): 9298 doi: 10.3390/ijms23169298
|
111 |
Zhiyuan Weng, Weijie Ou, Jiaofeng Huang, Medha Singh, Mingfang Wang, Yueyong Zhu, Rahul Kumar, Su Lin. Circadian Misalignment Rather Than Sleep Duration is Associated with MAFLD: A Population-Based Propensity Score-Matched Study. Nature and Science of Sleep 2021; : 103 doi: 10.2147/NSS.S290465
|
112 |
Seung Baek Hong, Nam Kyung Lee, Suk Kim, Kyunga Um, Keunyoung Kim, In Joo Kim. Hepatic Fat Quantification with the Multi-Material Decomposition Algorithm by Using Low-Dose Non-Contrast Material-Enhanced Dual-Energy Computed Tomography in a Prospectively Enrolled Cohort. Medicina 2022; 58(10): 1459 doi: 10.3390/medicina58101459
|
113 |
Rajesh R, Aditya Sangameshwar, Yi Yuan Tan, Kevin Teh Kim Jun, Tat Yean Tham, Mark Cheah Chang Chuen. Approach to Abnormal Liver Biochemistries in the Primary Care Setting. Cureus 2024; doi: 10.7759/cureus.56541
|
114 |
Katsutoshi Sugimoto, Masakazu Abe, Hisashi Oshiro, Hiroshi Takahashi, Tatsuya Kakegawa, Yusuke Tomita, Yu Yoshimasu, Hirohito Takeuchi, Takao Itoi. The most appropriate region-of-interest position for attenuation coefficient measurement in the evaluation of liver steatosis. Journal of Medical Ultrasonics 2021; 48(4): 615 doi: 10.1007/s10396-021-01124-z
|
115 |
Giovanna Ferraioli, Annalisa De Silvestri, Richard G. Barr. Does Meal or Water Intake Affect Ultrasound Attenuation Coefficient Estimate?. Journal of Ultrasound in Medicine 2024; 43(8): 1435 doi: 10.1002/jum.16465
|
116 |
Giovanna Ferraioli, Richard G. Barr. Quantification of Liver Steatosis: Is CT Equivalent to PDFF?. American Journal of Roentgenology 2021; 216(4): W14 doi: 10.2214/AJR.20.25069
|
117 |
Thomas Karlas, Valentin Blank, Corinna Trenker, André Ignee, Christoph F. Dietrich. Ultraschallgeräte für die abdominelle Diagnostik: neue Techniken und Applikationen – Was gibt es? Was ist möglich? Was ist sinnvoll?. Zeitschrift für Gastroenterologie 2023; 61(09): 1235 doi: 10.1055/a-1993-5356
|
118 |
Negar Abdi, Hamid Ghaznavi. CT attenuation values predict liver injury in COVID-19 patients. Egyptian Journal of Radiology and Nuclear Medicine 2024; 55(1) doi: 10.1186/s43055-024-01330-y
|
119 |
Qinrui Fu, Xiao Yang, Mengzhen Wang, Kang Zhu, Yin Wang, Jibin Song. Activatable Probes for Ratiometric Imaging of Endogenous BiomarkersIn Vivo. ACS Nano 2024; 18(5): 3916 doi: 10.1021/acsnano.3c10659
|
120 |
Yulei Wan, Dawei Wang, Hongbo Li, Ying Xu. The imaging techniques and diagnostic performance of ultrasound, CT, and MRI in detecting liver steatosis and fat quantification: A systematic review. Journal of Radiation Research and Applied Sciences 2023; 16(4): 100658 doi: 10.1016/j.jrras.2023.100658
|
121 |
Andrea Duminuco, Alessandra Cupri, Rosario Massimino, Salvatore Leotta, Giulio Antonio Milone, Bruno Garibaldi, Giulia Giuffrida, Orazio Garretto, Giuseppe Milone. Handheld Ultrasound or Conventional Ultrasound Devices in Patients Undergoing HCT: A Validation Study. Journal of Clinical Medicine 2023; 12(2): 520 doi: 10.3390/jcm12020520
|
122 |
Giovanna Ferraioli, Davide Roccarina, Richard G. Barr, Kathryn Fowler, Elizabeth Weintraub. Intersystem and Interoperator Agreement of US Attenuation Coefficient for Quantifying Liver Steatosis. Radiology 2024; 313(1) doi: 10.1148/radiol.240162
|
123 |
Hanying Liu, Xiao Li, Xiaodong Han, Yan Zhang, Yanting Gu, Lianjie Sun, Junfeng Han, Yinfang Tu, Yuqian Bao, Wenkun Bai, Haoyong Yu. Simple surrogate equations to predict controlled attenuation parameter values for screening non-alcoholic fatty liver disease in a Chinese population. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.894895
|
124 |
Haoxuan Zou, Xiaopu Ma, Fan Zhang, Yan Xie. Comparison of the diagnostic performance of twelve noninvasive scores of metabolic dysfunction-associated fatty liver disease. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01902-3
|
125 |
Olivia Hänni, Lisa Ruby, Catherine Paverd, Thomas Frauenfelder, Marga B. Rominger, Alexander Martin. Confounders of Ultrasound Attenuation Imaging in a Linear Probe Using the Canon Aplio i800 System: A Phantom Study. Diagnostics 2024; 14(3): 271 doi: 10.3390/diagnostics14030271
|
126 |
Christoph F. DIETRICH, Long SHI, Qi WEI, Yi DONG, Xin-Wu CUI, Axel LÖWE, Mathias WORNI, Giovanna FERRAIOLI. What does liver elastography measure? Technical aspects and methodology. Minerva Gastroenterology 2021; 67(2) doi: 10.23736/S2724-5985.20.02787-7
|
127 |
Jiawang Zou, Hailan Xiong, Huimin Zhang, Chong Hu, Song Lu, Yang Zou. Association between the cardiometabolic index and non-alcoholic fatty liver disease: insights from a general population. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02099-y
|
128 |
Vahid Sheikhi, Zahra Heidari. Association of Subclinical Hypothyroidism with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus. Advanced Biomedical Research 2022; 11(1): 124 doi: 10.4103/abr.abr_15_21
|
129 |
Kevin Kalisz, Patrick J. Navin, Malak Itani, Amit Kumar Agarwal, Sudhakar K. Venkatesh, Prabhakar Shantha Rajiah. Multimodality Imaging in Metabolic Syndrome: State-of-the-Art Review. RadioGraphics 2024; 44(3) doi: 10.1148/rg.230083
|
130 |
Samuel J Martínez-Domínguez, Sandra García-Mateo, Carla J Gargallo-Puyuelo, Beatriz Gallego-Llera, Pilar Callau, Carolina Mendi, María Teresa Arroyo-Villarino, Miguel Ángel Simón-Marco, Javier Ampuero, Fernando Gomollón. Inflammatory Bowel Disease Is an Independent Risk Factor for Metabolic Dysfunction–Associated Steatotic Liver Disease in Lean Individuals. Inflammatory Bowel Diseases 2024; 30(8): 1274 doi: 10.1093/ibd/izad175
|
131 |
Jae Seok Bae, Dong Ho Lee, Kyung-Suk Suh, Haeryoung Kim, Kyung Bun Lee, Jae Young Lee, Joon Koo Han. Noninvasive assessment of hepatic steatosis using a pathologic reference standard: comparison of CT, MRI, and US-based techniques. Ultrasonography 2022; 41(2): 344 doi: 10.14366/usg.21150
|
132 |
Karlo Mladenić, Maja Lenartić, Sonja Marinović, Bojan Polić, Felix M. Wensveen. The “Domino effect” in MASLD: The inflammatory cascade of steatohepatitis. European Journal of Immunology 2024; 54(4) doi: 10.1002/eji.202149641
|
133 |
Zheng Wang, Bohan Huang, Yixuan Ding, Feng Cao, Fei Li, Prof Fei Li. Association between life’s essential 8 and metabolic dysfunction-associated steatotic liver disease among US adults. Archives of Public Health 2024; 82(1) doi: 10.1186/s13690-024-01331-3
|
134 |
Shrivuthsun Srigandan, Marilyn Zelesco, Steven Abbott, Christopher J Welman. Correlation between hepatorenal index and attenuation imaging for assessing hepatic steatosis. Australasian Journal of Ultrasound in Medicine 2022; 25(3): 107 doi: 10.1002/ajum.12297
|
135 |
Abbas Avazpour, Mohadeseh Bahramnejad, Amir Hossein Hassani, Sara Matin, Maryam Moatamedi. Non-alcoholic Fatty Liver Disease in Overweight and Obese Children; Can Ultrasonography Substitute Laboratory Studies? A Case-Control Study. Iranian Journal of Pediatrics 2024; 34(5) doi: 10.5812/ijp-148096
|
136 |
Celal Ulasoglu, Zeynep Nilufer Tekin, Kubra Akan, Arda Yavuz. Does Nonalcoholic Pancreatic Steatosis Always Correlate with Nonalcoholic Fatty Liver Disease?. Clinical and Experimental Gastroenterology 2021; : 269 doi: 10.2147/CEG.S317340
|
137 |
A. Yu. Babenko, M. Yu. Laevskaya, A. R. Meltonian, Yu. N. Savchenkov, G. E. Trufanov. NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES: MODERN IMAGING MODALITIES. Translational Medicine 2023; 10(3): 146 doi: 10.18705/2311-4495-2023-10-2-146-153
|
138 |
Zahra Davoudi, Sina Raissi Dehkordi, Shahriar Nikpour, Masoud Shafiee, Ali Mohammadian, Yeganeh Farsi. Inflammatory and metabolic markers and comorbidities remission following sleeve gastrectomy: A single center one-year cohort study. Primary Care Diabetes 2023; 17(3): 273 doi: 10.1016/j.pcd.2023.03.001
|
139 |
Faezah Sabirin, Siong Meng Lim, Chin Fen Neoh, Kalavathy Ramasamy. Hepatoprotection of Probiotics Against Non-Alcoholic Fatty Liver Disease in vivo: A Systematic Review. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.844374
|
140 |
Jitka Starekova, Diego Hernando, Perry J. Pickhardt, Scott B. Reeder. Quantification of Liver Fat Content with CT and MRI: State of the Art. Radiology 2021; 301(2): 250 doi: 10.1148/radiol.2021204288
|
141 |
Richard G. Barr. Multiparametric Ultrasound for Chronic Liver Disease. Radiologic Clinics of North America 2025; 63(1): 13 doi: 10.1016/j.rcl.2024.07.003
|
142 |
Jaskamal Padda, Khizer Khalid, Anwar Khedr, Fahriba Tasnim, Ola A Al-Ewaidat, Ayden Charlene Cooper, Gutteridge Jean-Charles. Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus. Cureus 2021; doi: 10.7759/cureus.17321
|
143 |
Malte Niklas Bongers. Spectral Imaging. Medical Radiology 2022; : 235 doi: 10.1007/978-3-030-96285-2_15
|
144 |
Jin Cui, Lianbang Wang, Armin Ghavamian, Xuemei Li, Gongzheng Wang, Tao Wang, Min Huang, Qi Ru, Xinya Zhao. Long-term antibody response after the third dose of inactivated SARS-CoV-2 vaccine in MASLD patients. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03402-9
|
145 |
Metin Cetiner, Felix Schiepek, Ilja Finkelberg, Raphael Hirtz, Anja K. Büscher. Validation of attenuation imaging coefficient, shear wave elastography, and dispersion as emerging tools for non-invasive evaluation of liver tissue in children. Frontiers in Pediatrics 2023; 11 doi: 10.3389/fped.2023.1020690
|
146 |
Fuzhen Wan, Feng Pan, Oyekoya T. Ayonrinde, Leon A. Adams, Trevor A. Mori, Lawrence J. Beilin, Therese A. O'Sullivan, John K. Olynyk, Wendy H. Oddy. Validation of fatty liver disease scoring systems for ultrasound diagnosed non-alcoholic fatty liver disease in adolescents. Digestive and Liver Disease 2021; 53(6): 746 doi: 10.1016/j.dld.2020.11.037
|
147 |
Paulina Vidal-Cevallos, Alejandra Mijangos-Trejo, Misael Uribe, Norberto Chávez Tapia. The Interlink Between Metabolic-Associated Fatty Liver Disease and Polycystic Ovary Syndrome. Endocrinology and Metabolism Clinics of North America 2023; 52(3): 533 doi: 10.1016/j.ecl.2023.01.005
|
148 |
Hesham Mohamed Atef, Enas Mohamed Korayem, Naglaa Allam Ahmed, Mohamed Mohamed Houseni, Ahmed Mohamed El-Refaie, Manal Ibrahim Gomaa. Assessment of hepatic steatosis of potential living donor before liver transplantation using liver/spleen CT attenuation ratio compared to liver biopsy. Egyptian Journal of Radiology and Nuclear Medicine 2023; 54(1) doi: 10.1186/s43055-023-01165-z
|
149 |
Andrea Dalbeni, Marta Garbin, Mirko Zoncapè, Sara Romeo, Filippo Cattazzo, Anna Mantovani, Annalisa Cespiati, Anna Ludovica Fracanzani, Emmanouil Tsochatzis, David Sacerdoti, Alessandro Mantovani, Rosa Lombardi. Glomerular Hyperfiltration: A Marker of Fibrosis Severity in Metabolic Associated Steatotic Liver Disease in an Adult Population. International Journal of Molecular Sciences 2023; 24(21): 15837 doi: 10.3390/ijms242115837
|
150 |
Giovanna Ferraioli. Quantitative assessment of liver steatosis using ultrasound controlled attenuation parameter (Echosens). Journal of Medical Ultrasonics 2021; 48(4): 489 doi: 10.1007/s10396-021-01106-1
|
151 |
Raghu Ramanathan, Ahmad Hassan Ali, Jamal A. Ibdah. Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2022; 23(13): 7280 doi: 10.3390/ijms23137280
|
152 |
Wen-Pei Chang, Yu-Pei Chang. Correlation between Component Factors of Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome in Nurses: An Observational and Cross-Sectional Study. International Journal of Environmental Research and Public Health 2022; 19(23): 16294 doi: 10.3390/ijerph192316294
|
153 |
Maria Principia Scavo, Giuseppe Lisco, Nicoletta Depalo, Federica Rizzi, Sara Volpe, Valentina Arrè, Livianna Carrieri, Maria Notarnicola, Valentina De Nunzio, Maria Lucia Curri, Giovanni De Pergola, Giuseppina Piazzolla, Gianluigi Giannelli. Semaglutide Modulates Extracellular Matrix Production of LX-2 Cells via Exosomes and Improves Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). International Journal of Molecular Sciences 2024; 25(3): 1493 doi: 10.3390/ijms25031493
|
154 |
Shiwei Yang, Xiao Chen, Suen Chen, Hao Chen, Yue Zhao, Ziyue Wu, Hai Luo, Zhiyong Zhang. Radiofrequency coil design for improving human liver fat quantification in a portable single‐side magnetic resonance system. NMR in Biomedicine 2023; 36(5) doi: 10.1002/nbm.4875
|
155 |
Ozlem Deveci, Zuleyha Karaca, Fatih Tanriverdi, Kamil Deveci, Aysa Hacioglu, Kursad Unluhizarci, Fahrettin Kelestimur. Prediabetes and mild hepatosteatosis are associated with blunted cortisol response to glucagon but not to growth hormone. Annales d'Endocrinologie 2023; 84(2): 254 doi: 10.1016/j.ando.2022.11.003
|
156 |
Natascha Platz Batista da Silva, Gregor Scharf, Lukas Lürken, Niklas Verloh, Stephan Schleder, Christian Stroszczynski, Ernst Michael Jung, Michael Haimerl. Different Ultrasound Shear Wave Elastography Techniques as Novel Imaging-Based Approaches for Quantitative Evaluation of Hepatic Steatosis—Preliminary Findings. Tomography 2023; 9(2): 681 doi: 10.3390/tomography9020054
|
157 |
Nurullah Dag, Gulnur Igci, Fatma Hilal Yagin, Muhammed Salih Hanci, Ramazan Kutlu. Interobserver Reproducibility of Ultrasound Attenuation Imaging Technology in Liver Fat Quantification. Journal of Clinical Ultrasound 2024; doi: 10.1002/jcu.23877
|
158 |
Zi-Ming An, Qiao-Hong Liu, Xin-Jian Ye, Qian Zhang, Hua-Fu Pei, Xin Xin, Jie Yuan, Qian Huang, Kun Liu, Fang Lu, Zhi-Han Yan, Yu Zhao, Yi-Yang Hu, Ming-Hua Zheng, Qin Feng. A Novel Score Based on Controlled Attenuation Parameter Accurately Predicts Hepatic Steatosis in Individuals With Metabolic Dysfunction Associated Steatotic Liver Disease: A Derivation and Independent Validation Study. Clinical and Translational Gastroenterology 2024; 15(3): e00680 doi: 10.14309/ctg.0000000000000680
|
159 |
Ezgi KARAHAN, Zeynep GÖK SARGIN, Yücel ÜSTÜNDAĞ. Assessment of metabolic and inflammatory risk factors in patients with colorectal adenoma and carcinoma. Akademik Gastroenteroloji Dergisi 2022; 21(3): 115 doi: 10.17941/agd.1150314
|
160 |
Beatriz Sanchez de Blas, Alvaro G. Temprano, Jose J. G. Marin, Marta R. Romero. Monitoring the hepatobiliary function using image techniques and labeled cholephilic compounds. Exploration of Digestive Diseases 2023; : 18 doi: 10.37349/edd.2023.00015
|
161 |
Yoowon Kwon, Jin A Chung, You Jin Choi, Yoo Min Lee, So Yoon Choi, In Hyuk Yoo, Tae Hyeong Kim, Su Jin Jeong. Relationship of the Degree of Sarcopenia with the Severity of Nonalcoholic Fatty Liver Disease and Cardiometabolic Risk in Adolescents. Life 2024; 14(11): 1457 doi: 10.3390/life14111457
|
162 |
Xiaoxiao Wang, Xiaohe Li, Rui Jin, Jia Yang, Rui Huang, Lai Wei, Feng Liu, Huiying Rao. Mid‐upper arm circumference is associated with liver steatosis and fibrosis in patients with metabolic‐associated fatty liver disease: A population based observational study. Hepatology Communications 2022; 6(9): 2262 doi: 10.1002/hep4.1990
|
163 |
Carmela Morace, Selenia Lorenza Curatola, Giuseppe Mandraffino, Michele Scuruchi, Angela Elvira Serrano’, Angelo Tropeano, Fortunato Lombardo, Giuseppina Salzano, Giovanni Squadrito, Antonio Giovanni Versace, Mariella Valenzise. Serum endocan as a predictive biomarker of cardiovascular risk in obese pediatric patients. Italian Journal of Pediatrics 2023; 49(1) doi: 10.1186/s13052-023-01510-y
|
164 |
Chien-Chih Chen, Wei-Chien Hsu, Han-Ming Wu, Jiun-Yi Wang, Pei-Yu Yang, I-Ching Lin. Association between the Severity of Nonalcoholic Fatty Liver Disease and the Risk of Coronary Artery Calcification. Medicina 2021; 57(8): 807 doi: 10.3390/medicina57080807
|
165 |
Sebastian Merino, Roberto Lavarello. Spatially-Weighted Inverse Formulation for Enhanced Ultrasound Attenuation Imaging. 2024 IEEE International Symposium on Biomedical Imaging (ISBI) 2024; : 1 doi: 10.1109/ISBI56570.2024.10635654
|
166 |
Feng-Cheng Tang, Ren-Hau Li, Jui-Hua Huang. Unraveling the Connection between Fatty Liver Severity with Gender, Lifestyle, and Health Risks among Workers. Nutrients 2023; 15(22): 4765 doi: 10.3390/nu15224765
|
167 |
Antonietta Gerarda Gravina, Mario Romeo, Raffaele Pellegrino, Concetta Tuccillo, Alessandro Federico, Carmelina Loguercio. Just Drink a Glass of Water? Effects of Bicarbonate–Sulfate–Calcium–Magnesium Water on the Gut–Liver Axis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.869446
|
168 |
Baran Umut Vardar, Carolyn S. Dupuis, Alan J. Goldstein, Zeynep Vardar, Young H. Kim. Ultrasonographic evaluation of patients with abnormal liver function tests in the emergency department. Ultrasonography 2022; 41(2): 243 doi: 10.14366/usg.21152
|
169 |
Çağrı Damar, Emregül Işık, Şükrü Güngör. Relationship between Quantitative Sonographic Measurements and Serum Biochemical Parameters in Childhood Obesity. Pediatric Gastroenterology, Hepatology & Nutrition 2021; 24(5): 470 doi: 10.5223/pghn.2021.24.5.470
|
170 |
Ye-Na Kweon, Hae-Jin Ko, A-Sol Kim, Hye-In Choi, Ji-Eun Song, Ji-Yeon Park, Sung-Min Kim, Hee-Eun Hong, Kyung-Jin Min. Prediction of Cardiovascular Risk Using Nonalcoholic Fatty Liver Disease Scoring Systems. Healthcare 2021; 9(7): 899 doi: 10.3390/healthcare9070899
|
171 |
Akarshi Gupta, Rashmi Dixit, Anjali Prakash. Non-invasive hepatic fat quantification: Can multi-echo Dixon help?. Radiologia Brasileira 2024; 57 doi: 10.1590/0100-3984.2023.0125
|
172 |
Georgios Kalopitas, Thomai Mouskeftara, Theodoros Liapikos, Konstantinos Arvanitakis, Aristeidis Ioannidis, Konstantinos Malandris, Eleni Theocharidou, Michail Chourdakis, Emmanouil Sinakos, Helen Gika, Georgios Germanidis. Plasma Lipids Profile in the Prediction of Non-Alcoholic Steatohepatitis in Adults: A Case-Control Study. International Journal of Molecular Sciences 2023; 24(16): 12717 doi: 10.3390/ijms241612717
|
173 |
Ke-Yu Zeng, Wu-Yong-Ga Bao, Yun-Han Wang, Min Liao, Jie Yang, Jia-Yan Huang, Qiang Lu. Non-invasive evaluation of liver steatosis with imaging modalities: New techniques and applications. World Journal of Gastroenterology 2023; 29(17): 2534-2550 doi: 10.3748/wjg.v29.i17.2534
|
174 |
Geetika Khanna, Adina L. Alazraki. Quantitative US versus Quantitative MRI in the Assessment of Pediatric Chronic Liver Disease. Radiology 2022; 304(3): 670 doi: 10.1148/radiol.221066
|
175 |
Maria Irene Bellini, Irene Urciuoli, Giovanni Del Gaudio, Giorgia Polti, Giovanni Iannetti, Elena Gangitano, Eleonora Lori, Carla Lubrano, Vito Cantisani, Salvatore Sorrenti, Vito D’Andrea. Nonalcoholic fatty liver disease and diabetes. World Journal of Diabetes 2022; 13(9): 668-682 doi: 10.4239/wjd.v13.i9.668
|
176 |
Nobuharu Tamaki, Masayuki Kurosaki, Yuka Takahashi, Yoshie Itakura, Kento Inada, Sakura Kirino, Koji Yamashita, Shuhei Sekiguchi, Yuka Hayakawa, Leona Osawa, Mayu Higuchi, Kenta Takaura, Chiaki Maeyashiki, Shun Kaneko, Yutaka Yasui, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura, Namiki Izumi. Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease. Journal of Gastroenterology and Hepatology 2021; 36(10): 2960 doi: 10.1111/jgh.15589
|
177 |
Matteo Rosselli, Ioan Sporea, Giovanna Ferraioli. Liver Ultrasound. 2023; : 165 doi: 10.1002/9781119612650.ch9.2
|
178 |
Marco D’Abbondanza, Stefano Ministrini, Giacomo Pucci, Elisa Nulli Migliola, Eva-Edvige Martorelli, Vito Gandolfo, Donatella Siepi, Graziana Lupattelli, Gaetano Vaudo. Very Low-Carbohydrate Ketogenic Diet for the Treatment of Severe Obesity and Associated Non-Alcoholic Fatty Liver Disease: The Role of Sex Differences. Nutrients 2020; 12(9): 2748 doi: 10.3390/nu12092748
|
179 |
Prabhitha Geethakumari, Prathima Kampa, Rakesh Parchuri, Renu Bhandari, Ali R Alnasser, Aqsa Akram , Saikat Kar, Fatema Osman, Ghadi D Mashat, Hadrian Hoang-Vu Tran, Neway A Urgessa, Ann Kashmer Yu. Accuracy of Ultrasonography vs. Elastography in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review. Cureus 2022; doi: 10.7759/cureus.29967
|
180 |
Erika Paolini, Miriam Longo, Alberto Corsini, Paola Dongiovanni. The Non-Invasive Assessment of Circulating D-Loop and mt-ccf Levels Opens an Intriguing Spyhole into Novel Approaches for the Tricky Diagnosis of NASH. International Journal of Molecular Sciences 2023; 24(3): 2331 doi: 10.3390/ijms24032331
|
181 |
Simone Kresevic, Milos Ajcevic, Mauro Giuffrè, Pierpaolo Pupa, Lory Saveria Crocè, Agostino Accardo. 19th Nordic-Baltic Conference on Biomedical Engineering and Medical Physics. IFMBE Proceedings 2023; 89: 227 doi: 10.1007/978-3-031-37132-5_29
|
182 |
Mina AkbariRad, Masoud Pezeshki Rad, Hadi Nobakht, AmirAli Moodi Ghalibaf, Abdollah Firoozi, Ashkan Torshizian, Amir Reza Bina, Ali Beheshti Namdar, Masoumeh Sadeghi. Prevalence, characteristics, and risk factors of non-alcoholic fatty liver disease in North East of Iran: a population-based study. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03302-y
|
183 |
Gökhan VATANSEVER, Zeynep BOZKAN. Determination of the relationship between ultrasonographic examination of hepatic lipidosis and obesity assessment parameters in cats of different body conditions. Journal of Advances in VetBio Science and Techniques 2023; 8(1): 59 doi: 10.31797/vetbio.1211564
|
184 |
Xianjing Jin, Jing Xu, Xiaochun Weng. Correlation between ratio of fasting blood glucose to high density lipoprotein cholesterol in serum and non-alcoholic fatty liver disease in American adults: a population based analysis. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1428593
|
185 |
Tsung-Hsien Chou, Hsing-Jung Yeh, Chun-Chao Chang, Jui-Hsiang Tang, Wei-Yu Kao, I-Chia Su, Chien-Hung Li, Wei-Hao Chang, Chun-Kai Huang, Herdiantri Sufriyana, Emily Chia-Yu Su. Deep learning for abdominal ultrasound: A computer-aided diagnostic system for the severity of fatty liver. Journal of the Chinese Medical Association 2021; 84(9): 842 doi: 10.1097/JCMA.0000000000000585
|
186 |
Kyung Jae Lee, Jin Soo Moon, Nan Young Kim, Jae Sung Ko. Effects of PNPLA3, TM6SF2 and SAMM50 on the development and severity of non‐alcoholic fatty liver disease in children. Pediatric Obesity 2022; 17(2) doi: 10.1111/ijpo.12852
|
187 |
Hongyu Zhou, Yan Zhou, Jianmin Ding, Ying Chen, Jing Wen, Lei Zhao, Qian Zhang, Xiang Jing. Clinical evaluation of grayscale and linear scale hepatorenal indices for fatty liver quantification: a prospective study of a native Chinese population. Abdominal Radiology 2022; 47(4): 1321 doi: 10.1007/s00261-022-03434-3
|
188 |
Ovidiu Paul Calapod, Andreea Maria Marin, Anca Pantea Stoian, Carmen Fierbinteanu-Braticevici. Clinical Model for the Prediction of Severe Liver Fibrosis in Adult Patients with Type II Diabetes Mellitus. Diagnostics 2022; 12(8): 1829 doi: 10.3390/diagnostics12081829
|
189 |
Fatemeh Masaebi, Mehdi Azizmohammad Looha, Morteza Mohammadzadeh, Vida Pahlevani, Mojtaba Farjam, Farid Zayeri, Reza Homayounfar. Machine-Learning Application for Predicting Metabolic Dysfunction-Associated Steatotic Liver Disease Using Laboratory and Body Composition Indicators. Archives of Iranian Medicine 2024; 27(10): 551 doi: 10.34172/aim.31269
|
190 |
Patrick Stähli, Chiara Becchetti, Naiara Korta Martiartu, Annalisa Berzigotti, Martin Frenz, Michael Jaeger. First-in-human diagnostic study of hepatic steatosis with computed ultrasound tomography in echo mode. Communications Medicine 2023; 3(1) doi: 10.1038/s43856-023-00409-3
|
191 |
Gustavo Macedo HADDAD, Martinho Antonio GESTIC, Murillo Pimentel UTRINI, Felipe David Mendonça CHAIM, Elinton Adami CHAIM, Everton CAZZO. DIAGNOSTIC ACCURACY OF THE NON-INVASIVE MARKERS NFLS, NI-NASH-DS, AND FIB-4 FOR ASSESSMENT OF DIFFERENT ASPECTS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN INDIVIDUALS WITH OBESITY: CROSS-SECTIONAL STUDY. Arquivos de Gastroenterologia 2024; 61 doi: 10.1590/s0004-2803.24612023-050
|
192 |
Peter Robert Coombs, Mengistu Warsa, Tadiwos Hailu, Eskzyiaw Agedew, Behailu Tsegaye. Establishing an Ultrasound Screening Protocol for Chronic Liver Disease with a Handheld Device: A Pilot Project in Southern Ethiopia. Ultrasound in Medicine & Biology 2022; 48(4): 702 doi: 10.1016/j.ultrasmedbio.2021.12.013
|
193 |
James Fiori, Oyekoya Taiwo Ayonrinde. Letter: Are we forgetting the importance of steatosis in steatotic liver disease?. Alimentary Pharmacology & Therapeutics 2024; 59(2): 295 doi: 10.1111/apt.17759
|
194 |
Suo Yu Yan, Yi Wen Yang, Xin Yu Jiang, Su Hu, Yun Yan Su, Hui Yao, Chun Hong Hu. Fat quantification: Imaging methods and clinical applications in cancer. European Journal of Radiology 2023; 164: 110851 doi: 10.1016/j.ejrad.2023.110851
|
195 |
Nikolina-Alexia Fasoula, Angelos Karlas, Olga Prokopchuk, Nikoletta Katsouli, Michail Bariotakis, Evangelos Liapis, Anna Goetz, Michael Kallmayer, Josefine Reber, Alexander Novotny, Helmut Friess, Marc Ringelhan, Roland Schmid, Hans-Henning Eckstein, Susanna Hofmann, Vasilis Ntziachristos. Non-invasive multispectral optoacoustic tomography resolves intrahepatic lipids in patients with hepatic steatosis. Photoacoustics 2023; 29: 100454 doi: 10.1016/j.pacs.2023.100454
|
196 |
Duck Min Seo, Sang Min Lee, Ji Won Park, Min-Jeong Kim, Hong Il Ha, Sun-Young Park, Kwanseop Lee. How many times should we repeat measurements of the ultrasound-guided attenuation parameter for evaluating hepatic steatosis?. Ultrasonography 2023; 42(2): 227 doi: 10.14366/usg.22122
|
197 |
Luísa de Souza Echeverria, Daniel Leandro Saran Mounzer, Martinho Antonio Gestic, Murillo Pimentel Utrini, Felipe David Mendonça Chaim, Francisco Callejas-Neto, Elinton Adami Chaim, Everton Cazzo. Fibrotic NASH in Individuals with Obesity: a Cross-sectional Analysis of the Prevalence of this Significant Milestone of Disease Progression and Accuracy of a Non-invasive Marker for its Screening. Obesity Surgery 2024; 34(2): 389 doi: 10.1007/s11695-023-06998-1
|
198 |
Jiawei Wu, Fulong Liu, Weiqin Sun, Zhipeng Liu, Hui Hou, Rui Jiang, Haowei Hu, Peng Ren, Ran Zhang, Xiao Zhang. Boundary-aware convolutional attention network for liver segmentation in ultrasound images. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-70527-y
|
199 |
Ya Wang, Yajie Xu, Mingkang Zhang, Temitope Emmanuel Komolafe, Weiqian Wang, Hai Luo, Xiao Chen, Xiaodong Yang, Ziyue Wu. A single-sided magnet for deep-depth fat quantification. Journal of Magnetic Resonance 2021; 331: 107053 doi: 10.1016/j.jmr.2021.107053
|
200 |
Parisa Ghanbari, Roghayeh Alboebadi, Hadi Bazyar, Davoud Raiesi, Ahmad ZareJavid, Mohammad Karim Azadbakht, Mahdi Karimi, Hamidreza Razmi. Grape seed extract supplementation in non-alcoholic fatty liver disease. International Journal for Vitamin and Nutrition Research 2024; 94(5-6): 365 doi: 10.1024/0300-9831/a000805
|
201 |
Sergio J. Sanabria, Amir M. Pirmoazen, Jeremy Dahl, Aya Kamaya, Ahmed El Kaffas. Comparative Study of Raw Ultrasound Data Representations in Deep Learning to Classify Hepatic Steatosis. Ultrasound in Medicine & Biology 2022; 48(10): 2060 doi: 10.1016/j.ultrasmedbio.2022.05.031
|
202 |
Frano Susak, Nina Vrsaljko, Adriana Vince, Neven Papic. TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD—A Prospective Case–Control Study. Microorganisms 2023; 11(6): 1571 doi: 10.3390/microorganisms11061571
|
203 |
Maija Radzina, Davis Simanis Putrins, Arta Micena, Ieva Vanaga, Oksana Kolesova, Ardis Platkajis, Ludmila Viksna. Post‐COVID‐19 Liver Injury: Comprehensive Imaging With Multiparametric Ultrasound. Journal of Ultrasound in Medicine 2022; 41(4): 935 doi: 10.1002/jum.15778
|
204 |
Paolo Sorino, Angelo Campanella, Caterina Bonfiglio, Antonella Mirizzi, Isabella Franco, Antonella Bianco, Maria Gabriella Caruso, Giovanni Misciagna, Laura R. Aballay, Claudia Buongiorno, Rosalba Liuzzi, Anna Maria Cisternino, Maria Notarnicola, Marisa Chiloiro, Francesca Fallucchi, Giovanni Pascoschi, Alberto Rubén Osella. Development and validation of a neural network for NAFLD diagnosis. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-99400-y
|
205 |
Po-Ke Hsu, Li-Sha Wu, Wei-Wen Su, Pei-Yuan Su, Yang-Yuan Chen, Yu-Chun Hsu, Hsu-Heng Yen, Chia-Lin Wu, Jee-Fu Huang. Comparing the controlled attenuation parameter using FibroScan and attenuation imaging with ultrasound as a novel measurement for liver steatosis. PLOS ONE 2021; 16(10): e0254892 doi: 10.1371/journal.pone.0254892
|
206 |
Seung Min Chung, Min Kyu Kang, Jinho Jung, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee, Rohit Loomba, Jung Gil Park, Jun Sung Moon. Long-term effects of the changes in hepatic steatosis status on the risk of incident type 2 diabetes mellitus: A 15-year community-based prospective cohort study. Diabetes Research and Clinical Practice 2022; 184: 109208 doi: 10.1016/j.diabres.2022.109208
|
207 |
Milena Tauil Auad Noronha Santos, Cristiane Alves Villela-Nogueira, Nathalie Carvalho Leite, Patrícia de Fátima dos Santos Teixeira, Marcus Vinicius Leitão de Souza. Use of transient elastography for hepatic steatosis and fibrosis evaluation in patients with subclinical hypothyroidism. Archives of Endocrinology and Metabolism 2024; 68 doi: 10.20945/2359-4292-2023-0477
|
208 |
Akira Yamada, Eriko Yoshizawa. Quantitative assessment of liver steatosis using ultrasound: dual-energy CT. Journal of Medical Ultrasonics 2021; 48(4): 507 doi: 10.1007/s10396-021-01136-9
|
209 |
Yanan Zhao, Chao Zhang, Shaoyan Xu, Hui Zhang, Shumei Wei, Pengfei Huang, Lufei Zhang, Yik Ning Wong, Wen Xu, Pintong Huang. Quantitative evaluation of hepatic steatosis using novel ultrasound technology normalized local variance (NLV) and its standard deviation with different ROIs in patients with metabolic-associated fatty liver disease: a pilot study. Abdominal Radiology 2022; 47(2): 693 doi: 10.1007/s00261-021-03394-0
|
210 |
Pihou Gbande, Mazamaesso Tchaou, Huguette Diane Djoko Makamto, Massaga Dagbe, Lantam Sonhaye, Lama Kegdigoma Agoda-Koussema, Komlanvi Adjenou. Correlation between qualitative and semi-quantitative ultrasound assessment of diffuse fatty liver disease: A case-control study. Ultrasound 2024; 32(4): 253 doi: 10.1177/1742271X241241779
|
211 |
Adele Taibbi, Salvatore Petta, Domenica Matranga, Giovanni Caruana, Roberto Cannella, Gabriele Busè, Vito Di Marco, Massimo Midiri, Tommaso Vincenzo Bartolotta. Liver stiffness quantification in biopsy-proven nonalcoholic fatty liver disease patients using shear wave elastography in comparison with transient elastography. Ultrasonography 2021; 40(3): 407 doi: 10.14366/usg.20147
|
212 |
Ying Zhang, Kazushi Numata, Hiromi Nihonmatsu, Akihiro Funaoka, Haruo Miwa, Ritsuko Oishi, Akito Nozaki, Shin Maeda. Enhancing deep-seated hepatocellular carcinoma detection: assessing the added value of high mechanical index setting in sonazoid-based contrast-enhanced ultrasound during post-vascular phase. Journal of Medical Ultrasonics 2024; doi: 10.1007/s10396-024-01507-y
|
213 |
Aurélie D'Hondt, Erika Rubesova, Hua Xie, Vijay Shamdasani, Richard A. Barth. Liver Fat Quantification by Ultrasound in Children: A Prospective Study. American Journal of Roentgenology 2021; 217(4): 996 doi: 10.2214/AJR.20.24874
|
214 |
Kh.A. Moskva, O.P. Kikhtyak, M.L. Farmaha, Ya.L. Leshchuk, M.Yu. Horecha. Non-alcoholic fatty liver disease: new additional non-invasive diagnostic markers and risks of comorbid diseases. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 2024; 20(2): 99 doi: 10.22141/2224-0721.20.2.2024.1370
|
215 |
Clarissa Berardo, Laura Giuseppina Di Pasqua, Marta Cagna, Plinio Richelmi, Mariapia Vairetti, Andrea Ferrigno. Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research. International Journal of Molecular Sciences 2020; 21(24): 9646 doi: 10.3390/ijms21249646
|
216 |
Giovanna Ferraioli, Richard Gary Barr, Annalisa Berzigotti, Ioan Sporea, Vincent Wai‐Sun Wong, Thomas Reiberger, Thomas Karlas, Maja Thiele, Ana Carolina Cardoso, Oyekoya Taiwo Ayonrinde, Laurent Castera, Christoph Frank Dietrich, Hiroko Iijima, Dong Ho Lee, William Kemp, Claudia P. Oliveira, Shiv Kumar Sarin. WFUMB Guidelines/Guidance on Liver Multiparametric Ultrasound. Part 2: Guidance on Liver Fat Quantification. Ultrasound in Medicine & Biology 2024; 50(8): 1088 doi: 10.1016/j.ultrasmedbio.2024.03.014
|
217 |
Uday Kumar Marri, Kumble Seetharama Madhusudhan. Dual-Energy Computed Tomography in Diffuse Liver Diseases. Journal of Gastrointestinal and Abdominal Radiology 2022; 5(02): 094 doi: 10.1055/s-0042-1742432
|
218 |
Jiawen Huo, Aizhi Peng, Fenfang Chen, Fen Chen, Lanling Shen, Hongxia Yan, Ahmed Faeq Hussein. Efficacy Evaluation of Ultrasound with Active Contour Model for Hemodialysis in Children with Renal Failure. Computational and Mathematical Methods in Medicine 2022; 2022: 1 doi: 10.1155/2022/3665841
|
219 |
Sun Kyung Jeon, Jeong Min Lee, Ijin Joo, Jeong Hee Yoon. Assessment of the inter-platform reproducibility of ultrasound attenuation examination in nonalcoholic fatty liver disease. Ultrasonography 2022; 41(2): 355 doi: 10.14366/usg.21167
|
220 |
Teodora Biciusca, Sorina Ionelia Stan, Mara Amalia Balteanu, Ramona Cioboata, Alice Elena Ghenea, Suzana Danoiu, Ana-Maria Bumbea, Viorel Biciusca. The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review. Diagnostics 2023; 13(21): 3316 doi: 10.3390/diagnostics13213316
|
221 |
Sara Volpe, Alfredo Vozza, Giuseppe Lisco, Margherita Fanelli, Davide Racaniello, Alessandro Bergamasco, Domenico Triggiani, Giulia Pierangeli, Giovanni De Pergola, Cosimo Tortorella, Antonio Moschetta, Giuseppina Piazzolla. Sodium-Glucose Cotransporter 2 Inhibitors Improve Body Composition by Increasing the Skeletal Muscle Mass/Fat Mass Ratio in Patients with Type 2 Diabetes: A 52-Week Prospective Real-Life Study. Nutrients 2024; 16(22): 3841 doi: 10.3390/nu16223841
|
222 |
Rosa Lombardi, Lucia Colavolpe, Francesca Alletto, Annalisa Cespiati, Erika Fatta, Cristina Bertelli, Felice Cinque, Giuseppina Pisano, Edoardo Pulixi, Paolo Francione, Gabriele Maffi, Federica Iuculano, Paola Dongiovanni, Marica Meroni, Larry Burdick, Daniela Bignamini, Marco Maggioni, Luca Valenti, Silvia Fargion, Anna Ludovica Fracanzani. Comparison of the severity of metabolic, liver and cardiovascular damage in NAFLD patients attending the hepatology clinic over the last three decades. Digestive and Liver Disease 2024; 56(1): 144 doi: 10.1016/j.dld.2023.07.009
|
223 |
J.A. Velarde-Ruiz Velasco, D.K. Tapia Calderón, E. Llop Herrera, G. Castro Narro, E.S. García Jiménez, E. Cerda Reyes, F. Higuera de la Tijera, A.D. Cano Contreras, R. Moreno Alcántar, R.M. Chávez Ramírez, J.L. Calleja Panero. Beyond conventional physical examination in hepatology: POCUS. Revista de Gastroenterología de México (English Edition) 2023; 88(4): 381 doi: 10.1016/j.rgmxen.2023.07.003
|
224 |
Yaw A Wiafe, Ijeoma C Anyitey-Kokor, Richmond A Nmai, Mary Afihene, Lewis R Roberts. Diagnostic Performance of Greyscale Ultrasound in Detecting Fatty Liver Disease in a Type 2 Diabetes Population Using FibroScan as the Reference Standard. Cureus 2023; doi: 10.7759/cureus.40756
|
225 |
Masoud Nouri-Vaskeh, Payam Hashemi, Naser Hataminia, Yalda Yazdani, Mahkameh Nasirian, Leila Alizadeh. The impact of piperine on the metabolic conditions of patients with NAFLD and early cirrhosis: a randomized double-blind controlled trial. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-51726-z
|
226 |
Felice Cinque, Annalisa Cespiati, Rosa Lombardi, Andrea Costantino, Gabriele Maffi, Francesca Alletto, Lucia Colavolpe, Paolo Francione, Giovanna Oberti, Erika Fatta, Cristina Bertelli, Giordano Sigon, Paola Dongiovanni, Maurizio Vecchi, Silvia Fargion, Anna Ludovica Fracanzani. Interaction between Lifestyle Changes and PNPLA3 Genotype in NAFLD Patients during the COVID-19 Lockdown. Nutrients 2022; 14(3): 556 doi: 10.3390/nu14030556
|
227 |
Davide Ippolito, Cesare Maino, Federica Vernuccio, Roberto Cannella, Riccardo Inchingolo, Michele Dezio, Riccardo Faletti, Pietro Andrea Bonaffini, Marco Gatti, Sandro Sironi. Liver involvement in patients with COVID-19 infection: A comprehensive overview of diagnostic imaging features. World Journal of Gastroenterology 2023; 29(5): 834-850 doi: 10.3748/wjg.v29.i5.834
|
228 |
Mauro Giuffrè, Michela Giuricin, Deborah Bonazza, Natalia Rosso, Pablo José Giraudi, Flora Masutti, Stefano Palmucci, Antonio Basile, Fabrizio Zanconati, Nicolò de Manzini, Claudio Tiribelli, Silvia Palmisano, Lory Saveria Crocè. Optimization of Point-Shear Wave Elastography by Skin-to-Liver Distance to Assess Liver Fibrosis in Patients Undergoing Bariatric Surgery. Diagnostics 2020; 10(10): 795 doi: 10.3390/diagnostics10100795
|
229 |
Giovanna Ferraioli, Annalisa De Silvestri, Gabriela Torres, Richard G. Barr. Ultrasound backscatter coefficient for fat quantification is affected by the measurement depth. Abdominal Radiology 2024; 49(8): 2622 doi: 10.1007/s00261-024-04413-6
|
230 |
A. O. Rozhdestvenska, N. M. Zhelezniakova. Cluster Analysis as a Method of Assessing the Severity of Non-Alcoholic Fatty Liver Disease in Patients with Hypertension. Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 2021; 6(5): 239 doi: 10.26693/jmbs06.05.239
|
231 |
Q Binet, A Loumaye, V Preumont, J-P Thissen, M.P. Hermans, N Lanthier. Non-invasive screening, staging and management of metabolic dysfunction-associated fatty liver disease (MAFLD) in type 2 diabetes mellitus patients : what do we know so far ?. Acta Gastro Enterologica Belgica 2022; 85(2): 346 doi: 10.51821/85.2.9775
|
232 |
Vicneswarry Dorairaj, Siti Aishah Sulaiman, Nadiah Abu, Nor Azian Abdul Murad. Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis. Biomedicines 2021; 10(1): 15 doi: 10.3390/biomedicines10010015
|
233 |
Yasser Fouad, Mohamed Alboraie, Gamal Shiha. Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver disease. Hepatology International 2024; 18(S2): 827 doi: 10.1007/s12072-024-10704-3
|
234 |
Giovanna Ferraioli, Richard G. Barr. Ultrasound evaluation of chronic liver disease. Abdominal Radiology 2024; doi: 10.1007/s00261-024-04568-2
|
235 |
Nobuharu TAMAKI, Masayuki KUROSAKI, Yutaka YASUI, Kaoru TSUCHIYA, Namiki IZUMI. Attenuation coefficient (ATT) measurement for liver fat quantification in chronic liver disease. Choonpa Igaku 2023; 50(3): 171 doi: 10.3179/jjmu.JJMU.R.220
|
236 |
Carl F. Sabottke, Bradley M. Spieler, Ahmed W. Moawad, Khaled M. Elsayes. Artificial Intelligence in Imaging of Chronic Liver Diseases. Magnetic Resonance Imaging Clinics of North America 2021; 29(3): 451 doi: 10.1016/j.mric.2021.05.011
|
237 |
Lulu Wang, Xiangcheng Fan, Jichun Han, Minxuan Cai, Xiaozhong Wang, Yan Wang, Jing Shang. Gut-Derived Serotonin Contributes to the Progression of Non-Alcoholic Steatohepatitis via the Liver HTR2A/PPARγ2 Pathway. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00553
|
238 |
Haoxuan Zou, Fanrong Zhao, Xiuhe Lv, Xiaopu Ma, Yan Xie. Development and validation of a new nomogram to screen for MAFLD. Lipids in Health and Disease 2022; 21(1) doi: 10.1186/s12944-022-01748-1
|
239 |
Ansh Tandon, Joseph Moneim, Lauren Hector, Peter Fletcher, Ishpal Moonga, Sarah Fawcett, Helen Taylor, Cecilia Brassett. A national survey on the use of ultrasound as an educational tool to complement anatomy teaching at UK medical schools. Clinical Anatomy 2024; doi: 10.1002/ca.24229
|
240 |
Dorotea Bozic, Kristian Podrug, Ivana Mikolasevic, Ivica Grgurevic. Ultrasound Methods for the Assessment of Liver Steatosis: A Critical Appraisal. Diagnostics 2022; 12(10): 2287 doi: 10.3390/diagnostics12102287
|
241 |
Xiongcai Feng, Junzhao Ye, Hong Deng, Xin Li, Lishu Xu, Shiting Feng, Zhi Dong, Bing Liao, Zhiyong Dong, Bihui Zhong. An Optimized Strategy Based on Conventional Ultrasound for Diagnosing Metabolic Dysfunction-Associated Steatotic Liver Disease. Diagnostics 2023; 13(23): 3503 doi: 10.3390/diagnostics13233503
|
242 |
Chang-Hai Liu, Shanshan Zheng, Shisheng Wang, Dongbo Wu, Wei Jiang, Qingmin Zeng, Yi Wei, Yong Zhang, Hong Tang. Urine Proteome in Distinguishing Hepatic Steatosis in Patients with Metabolic-Associated Fatty Liver Disease. Diagnostics 2022; 12(6): 1412 doi: 10.3390/diagnostics12061412
|
243 |
Aleksandra Hliwa, Bruno Ramos-Molina, Dariusz Laski, Adriana Mika, Tomasz Sledzinski. The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update. International Journal of Molecular Sciences 2021; 22(13): 6900 doi: 10.3390/ijms22136900
|
244 |
Yang Zou, Jianyun Lan, Yanjia Zhong, Shuo Yang, Huimin Zhang, Guobo Xie. Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01573-y
|
245 |
V. V. Gorban, E. V. Matveeva, E. V. Gorban, E. S. Kameneva. The possibilities of transabdominal sonographic diagnosis of liver and intestinal lesions in comorbid gastroesophageal reflux disease. Meditsinskiy sovet = Medical Council 2022; (15): 134 doi: 10.21518/2079-701X-2022-16-15-134-143
|
246 |
Polina Soluyanova, Marta del Pozo, Erika Moro-Castaño, Ana V. Marco-Hernández, José V. Castell, Ramiro Jover. A microRNA signature for valproate-induced steatosis in human hepatocytes and its application to predict fatty liver in paediatric epileptic patients on valproate therapy. Toxicology 2024; 509: 153974 doi: 10.1016/j.tox.2024.153974
|
247 |
Cesare Maino, Federica Vernuccio, Roberto Cannella, Paolo Niccolò Franco, Valentina Giannini, Michele Dezio, Antonio Rosario Pisani, Antonino Andrea Blandino, Riccardo Faletti, Elisabetta De Bernardi, Davide Ippolito, Marco Gatti, Riccardo Inchingolo. Radiomics and liver: Where we are and where we are headed?. European Journal of Radiology 2024; 171: 111297 doi: 10.1016/j.ejrad.2024.111297
|
248 |
Giovanna Ferraioli, Richard Gary Barr, Annalisa Berzigotti, Ioan Sporea, Vincent Wai‐Sun Wong, Thomas Reiberger, Thomas Karlas, Maja Thiele, Ana Carolina Cardoso, Oyekoya Taiwo Ayonrinde, Laurent Castera, Christoph Frank Dietrich, Hiroko Iijima, Dong Ho Lee, William Kemp, Claudia P. Oliveira, Shiv Kumar Sarin. WFUMB Guideline/Guidance on Liver Multiparametric Ultrasound: Part 1. Update to 2018 Guidelines on Liver Ultrasound Elastography. Ultrasound in Medicine & Biology 2024; 50(8): 1071 doi: 10.1016/j.ultrasmedbio.2024.03.013
|
249 |
Mariasole Mazzola, Roberto Cannella, Giulia Pilato, Antonino Andrea Blandino, Monica Milazzo, Francesco Matteini, Federica Vernuccio, Giuseppe Brancatelli. Quantitative liver MRI biomarkers: what the radiologist should know. Journal of Medical Imaging and Interventional Radiology 2024; 11(1) doi: 10.1007/s44326-024-00015-0
|
250 |
Jia-yi Tian, Meng Xiao, Wen-wen Zhao, Xia Wu, Jie Yang, Xiao-qing Chen. Effect of Ilex hainanensis Merr. On HFD-induced nonalcoholic fatty liver disease and rebalance of gut microbiota and bile acids metabolism in mice. Fitoterapia 2024; 178: 106186 doi: 10.1016/j.fitote.2024.106186
|
251 |
Ivan M. Rosado-Mendez, Timothy J. Hall. Quantitative Imaging in Medicine. 2021; : 4-1 doi: 10.1063/9780735423558_004
|
252 |
Thomas Karlas, Valentin Blank, Albrecht Böhlig. Diagnostic Value of Ultrasound in Fatty Liver Disease. Ultraschall in der Medizin - European Journal of Ultrasound 2021; 42(02): 128 doi: 10.1055/a-1352-4313
|
253 |
Oana Irina Gavril, Irina Mihaela Esanu, Ioana Madalina Zota, Iolanda Valentina Popa, Lidia Iuliana Arhire, Diana Tatarciuc, Alexandra Mastaleru, Andrei Drugescu, Radu Sebastian Gavril, Mariana Graur, Florin Mitu. Hepatic Steatosis in Patients with Chronic Viral Hepatitis C Treated with Direct Acting Antivirals. Internal Medicine 2023; 20(2): 55 doi: 10.2478/inmed-2023-0247
|
254 |
Linda Calistri, Vieri Rastrelli, Cosimo Nardi, Davide Maraghelli, Sofia Vidali, Michele Pietragalla, Stefano Colagrande. Imaging of the chemotherapy-induced hepatic damage: Yellow liver, blue liver, and pseudocirrhosis. World Journal of Gastroenterology 2021; 27(46): 7866-7893 doi: 10.3748/wjg.v27.i46.7866
|
255 |
Woo Sun Rou. Assessment of Hepatic Steatosis Using Ultrasound-Based Techniques: Focus on Fat Quantification. Clinical Ultrasound 2024; 9(1): 1 doi: 10.18525/cu.2024.9.1.1
|
256 |
Mahinur Cerit, Halit Nahit Şendur, Emetullah Cindil, Gonca Erbaş, Mehmet Muhittin Yalçın, Ethem Turgay Cerit, Seriyye Allahverdiyeva, Suna Özhan Oktar, Cem Yücel. Quantification of liver fat content with ultrasonographic attenuation measurement function: Correlation with unenhanced multidimensional computerized tomography. Clinical Imaging 2020; 65: 85 doi: 10.1016/j.clinimag.2020.04.028
|
257 |
Guotai Sheng, Song Lu, Qiyang Xie, Nan Peng, Maobin Kuang, Yang Zou. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01561-2
|
258 |
Yong Xie, Huan Tian, Bin Xiang, Ding Li, Jian Liu, Zhuoyan Cai, Yuzhou Liu, Hua Xiang. Total polyunsaturated fatty acid intake and the risk of non-alcoholic fatty liver disease in Chinese Han adults: a secondary analysis based on a case–control study. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-02039-2
|
259 |
Christopher J Welman, Jacqualine Saunders, Marilyn Zelesco, Steven Abbott, Glenn Boardman, Oyekoya T Ayonrinde. Hepatic steatosis: Ultrasound assessment using attenuation imaging (ATI) with liver biopsy correlation. Journal of Medical Imaging and Radiation Oncology 2023; 67(1): 45 doi: 10.1111/1754-9485.13412
|
260 |
Mehnoosh Torkzaban, Corinne E. Wessner, Dina Halegoua-DeMarzio, Shuchi K. Rodgers, Andrej Lyshchik, Kibo Nam. Diagnostic Performance Comparison Between Ultrasound Attenuation Measurements From Right and Left Hepatic Lobes for Steatosis Detection in Non-alcoholic Fatty Liver Disease. Academic Radiology 2023; 30(9): 1838 doi: 10.1016/j.acra.2022.12.025
|
261 |
Ziming An, Qiaohong Liu, Wenli Zeng, Yan Wang, Qian Zhang, Huafu Pei, Xin Xin, Shuohui Yang, Fang Lu, Yu Zhao, Yiyang Hu, Qin Feng. Relationship between controlled attenuated parameter and magnetic resonance imaging–proton density fat fraction for evaluating hepatic steatosis in patients with NAFLD. Hepatology Communications 2022; 6(8): 1975 doi: 10.1002/hep4.1948
|
262 |
Luigi Mirarchi, Simona Amodeo, Roberto Citarrella, Anna Licata, Maurizio Soresi, Lydia Giannitrapani. SGLT2 Inhibitors as the Most Promising Influencers on the Outcome of Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2022; 23(7): 3668 doi: 10.3390/ijms23073668
|
263 |
Shuying Li, Li Feng, Jie Ding, Weihong Zhou, Tangbin Yuan, Jiangfeng Mao. Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-03007-8
|
264 |
Hyun Jin Kim. Significance of Triglyceride-to-High-Density Lipoprotein Cholesterol Ratio in Children with Non-Alcoholic Fatty Liver Disease. Pediatric Gastroenterology, Hepatology & Nutrition 2023; 26(6): 312 doi: 10.5223/pghn.2023.26.6.312
|
265 |
Mesut Bulakci, Celal Caner Ercan, Edanur Karapinar, Melike Zeynep Tugrul Aksakal, Shamil Aliyev, Fuat Bicen, Aylin Yetim Sahin, Artur Salmaslioglu. Quantitative evaluation of hepatic steatosis using attenuation imaging in a pediatric population: a prospective study. Pediatric Radiology 2023; 53(8): 1629 doi: 10.1007/s00247-023-05615-8
|
266 |
Paul S. Sidhu, Cheng Fang. US-based Hepatic Fat Quantification: An Emerging Technique and Game Changer?. Radiology 2023; 307(1) doi: 10.1148/radiol.223002
|
267 |
Ana Carolina Cardoso, Cristiane A. Villela-Nogueira, Cláudio de Figueiredo-Mendes, Hilton Leão Filho, Rogério Augusto Pinto Silva, Cristiane Valle Tovo, Hugo Perazzo, Antonio Carlos Matteoni, Roberto José de Carvalho-Filho, Paulo Lisboa Bittencourt. Brazilian Society of Hepatology and Brazilian College of Radiology practice guidance for the use of elastography in liver diseases. Annals of Hepatology 2021; 22: 100341 doi: 10.1016/j.aohep.2021.100341
|
268 |
Menglong Li, Wen Shu, Jiawulan Zunong, Nubiya Amaerjiang, Huidi Xiao, Dan Li, Sten H. Vermund, Yifei Hu. Predictors of non-alcoholic fatty liver disease in children. Pediatric Research 2022; 92(1): 322 doi: 10.1038/s41390-021-01754-6
|
269 |
Duanghathai Pasanta, Khin Thandar Htun, Jie Pan, Montree Tungjai, Siriprapa Kaewjaeng, Hongjoo Kim, Jakrapong Kaewkhao, Suchart Kothan. Magnetic Resonance Spectroscopy of Hepatic Fat from Fundamental to Clinical Applications. Diagnostics 2021; 11(5): 842 doi: 10.3390/diagnostics11050842
|
270 |
Carlo De Matteis, Lucilla Crudele, Ersilia Di Buduo, Salvatore Cantatore, Raffaella Maria Gadaleta, Marica Cariello, Patrizia Suppressa, Gianfranco Antonica, Elsa Berardi, Giusi Graziano, Antonio Moschetta. Hyperhomocysteinemia is linked to MASLD. European Journal of Internal Medicine 2024; doi: 10.1016/j.ejim.2024.10.014
|
271 |
Jing Gao. Ultrasound attenuation coefficient of the liver and spleen in adults: A preliminary observation. Clinical Imaging 2022; 84: 140 doi: 10.1016/j.clinimag.2022.02.010
|
272 |
Ludovico Abenavoli, Rocco Spagnuolo, Giuseppe Guido Maria Scarlata, Emidio Scarpellini, Luigi Boccuto, Francesco Luzza. Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study. Medicina 2023; 59(11): 1935 doi: 10.3390/medicina59111935
|
273 |
Giovanna Ferraioli, Ambra Raimondi, Laura Maiocchi, Annalisa De Silvestri, Carlo Filice. Quantification of Liver Fat Content with the iATT Algorithm: Correlation with Controlled Attenuation Parameter. Diagnostics 2022; 12(8): 1787 doi: 10.3390/diagnostics12081787
|
274 |
Giorgia Polti, Francesco Frigerio, Giovanni Del Gaudio, Patrizia Pacini, Vincenzo Dolcetti, Maurizio Renda, Sergio Angeletti, Michele Di Martino, Giovanni Iannetti, Francesco Massimo Perla, Eleonora Poggiogalle, Vito Cantisani. Quantitative ultrasound fatty liver evaluation in a pediatric population: comparison with magnetic resonance imaging of liver proton density fat fraction. Pediatric Radiology 2023; 53(12): 2458 doi: 10.1007/s00247-023-05749-9
|
275 |
Ekrem Aksu, Abdullah Sokmen, Murat Ispiroglu, Kadir Gisi, Enes Celik, Ahmet Cagri Aykan. Early cardiac electrical and structural changes in patients with non-obese non-alcoholic fatty liver disease. Kardiologiia 2021; 61(5): 51 doi: 10.18087/cardio.2021.5.n1416
|
276 |
Parisa Ghanbari, Davoud Raiesi, Roghayeh Alboebadi, Ahmad Zarejavid, Mostafa Dianati, Hamidreza Razmi, Hadi Bazyar. The effects of grape seed extract supplementation on cardiovascular risk factors, liver enzymes and hepatic steatosis in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study. BMC Complementary Medicine and Therapies 2024; 24(1) doi: 10.1186/s12906-024-04477-3
|
277 |
Jie Chen, Jiang Yue, Jingjing Fu, Shengyun He, Qianjing Liu, Minglan Yang, Wang Zhang, Hua Xu, Qing Lu, Jing Ma. A prediction model of liver fat fraction and presence of non-alcoholic fatty liver disease (NAFLD) among patients with overweight or obesity. Endocrine Journal 2023; 70(10): 977 doi: 10.1507/endocrj.EJ23-0227
|
278 |
Florentina Ionita-Radu, Cristina Patoni, Andreea Simona Nancoff, Flavius-Stefan Marin, Laura Gaman, Ana Bucurica, Calin Socol, Mariana Jinga, Madalina Dutu, Sandica Bucurica. Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease—Clinical and Pre-Clinical Overview and Systematic Review of the Literature. International Journal of Molecular Sciences 2024; 25(8): 4201 doi: 10.3390/ijms25084201
|
279 |
Isabel Molwitz, Miriam Leiderer, Cansu Özden, Jin Yamamura. Dual-Energy Computed Tomography for Fat Quantification in the Liver and Bone Marrow: A Literature Review. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 2020; 192(12): 1137 doi: 10.1055/a-1212-6017
|
280 |
Lim Rong, Daniel Ch'ng, Pingping Jia, Kelvin K F Tsoi, Sunny H Wong, Joseph J Y Sung. Use of probiotics, prebiotics, and synbiotics in non‐alcoholic fatty liver disease: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 2023; 38(10): 1682 doi: 10.1111/jgh.16256
|